ONTOLOGY REPORT - ANNOTATIONS
| Term: | main group element atom |
|
| Accession: | CHEBI:33318
|
browse the term
|
| Definition: | An atom belonging to one of the main groups (found in the s- and p- blocks) of the periodic table. |
| Synonyms: | exact_synonym: | main group elements |
| | related_synonym: | Hauptgruppenelement; Hauptgruppenelemente; main group element |
|
|
calcium atom
|
| G |
Abp1 |
amiloride binding protein 1 (amine oxidase, copper-containing) |
|
affects binding |
ISO |
4 |
76,957,477 |
76,977,643 |
RGD:6480464 |
CTD |
| G |
Aco2 |
aconitase 2, mitochondrial |
|
increases activity |
ISO |
7 |
120,223,788 |
120,266,944 |
RGD:6480464 |
CTD |
| G |
Aco2 |
aconitase 2, mitochondrial |
|
multiple interactions |
ISO |
7 |
120,223,788 |
120,266,944 |
RGD:6480464 |
CTD |
| G |
Actb |
actin, beta |
|
multiple interactions |
EXP |
12 |
12,047,070 |
12,050,040 |
RGD:6480464 |
CTD |
| G |
Adcy5 |
adenylate cyclase 5 |
|
decreases activity |
ISO |
11 |
67,290,968 |
67,437,468 |
RGD:6480464 |
CTD |
| G |
Adcy5 |
adenylate cyclase 5 |
|
increases response to substance |
ISO |
11 |
67,290,968 |
67,437,468 |
RGD:6480464 |
CTD |
| G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
increases abundance |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
affects abundance |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Adm |
adrenomedullin |
|
decreases expression |
ISO |
1 |
168,380,255 |
168,382,426 |
RGD:6480464 |
CTD |
| G |
Adra1a |
adrenoceptor alpha 1A |
|
multiple interactions |
ISO |
15 |
46,173,429 |
46,263,198 |
RGD:6480464 |
CTD |
| G |
Adra1a |
adrenoceptor alpha 1A |
|
multiple interactions |
ISO |
15 |
46,173,429 |
46,263,198 |
RGD:6480464 |
CTD |
| G |
Adra1a |
adrenoceptor alpha 1A |
|
multiple interactions |
ISO |
15 |
46,173,429 |
46,263,198 |
RGD:6480464 |
CTD |
| G |
Adra1a |
adrenoceptor alpha 1A |
|
multiple interactions |
EXP |
15 |
46,173,429 |
46,263,198 |
RGD:6480464 |
CTD |
| G |
Adra1a |
adrenoceptor alpha 1A |
|
affects transport |
EXP |
15 |
46,173,429 |
46,263,198 |
RGD:6480464 |
CTD |
| G |
Adra1a |
adrenoceptor alpha 1A |
|
multiple interactions |
EXP |
15 |
46,173,429 |
46,263,198 |
RGD:6480464 |
CTD |
| G |
Adra1a |
adrenoceptor alpha 1A |
|
multiple interactions |
ISO |
15 |
46,173,429 |
46,263,198 |
RGD:6480464 |
CTD |
| G |
Adra1a |
adrenoceptor alpha 1A |
|
multiple interactions |
ISO |
15 |
46,173,429 |
46,263,198 |
RGD:6480464 |
CTD |
| G |
Adra1b |
adrenoceptor alpha 1B |
|
multiple interactions |
ISO |
10 |
28,889,092 |
28,946,889 |
RGD:6480464 |
CTD |
| G |
Adra1b |
adrenoceptor alpha 1B |
|
multiple interactions |
ISO |
10 |
28,889,092 |
28,946,889 |
RGD:6480464 |
CTD |
| G |
Adra1b |
adrenoceptor alpha 1B |
|
multiple interactions |
ISO |
10 |
28,889,092 |
28,946,889 |
RGD:6480464 |
CTD |
| G |
Adra1b |
adrenoceptor alpha 1B |
|
multiple interactions |
ISO |
10 |
28,889,092 |
28,946,889 |
RGD:6480464 |
CTD |
| G |
Adra1b |
adrenoceptor alpha 1B |
|
multiple interactions |
ISO |
10 |
28,889,092 |
28,946,889 |
RGD:6480464 |
CTD |
| G |
Adra1d |
adrenoceptor alpha 1D |
|
multiple interactions |
ISO |
3 |
119,279,974 |
119,295,985 |
RGD:6480464 |
CTD |
| G |
Adra1d |
adrenoceptor alpha 1D |
|
multiple interactions |
ISO |
3 |
119,279,974 |
119,295,985 |
RGD:6480464 |
CTD |
| G |
Adra2a |
adrenoceptor alpha 2A |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Adra2b |
adrenoceptor alpha 2B |
|
multiple interactions |
ISO |
3 |
114,867,357 |
114,869,680 |
RGD:6480464 |
CTD |
| G |
Adra2c |
adrenoceptor alpha 2C |
|
multiple interactions |
ISO |
14 |
81,107,907 |
81,109,610 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
EXP |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
increases uptake |
ISO |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions |
ISO |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions |
ISO |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
increases abundance |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
affects localization |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agtr1a |
angiotensin II receptor, type 1a |
|
affects expression |
EXP |
17 |
40,629,318 |
40,684,982 |
RGD:6480464 |
CTD |
| G |
Agtr1b |
angiotensin II receptor, type 1b |
|
multiple interactions |
EXP |
2 |
105,503,269 |
105,602,591 |
RGD:6480464 |
CTD |
| G |
Akap1 |
A kinase (PRKA) anchor protein 1 |
|
affects expression |
EXP |
10 |
77,262,592 |
77,276,832 |
RGD:6480464 |
CTD |
| G |
Akap11 |
A kinase (PRKA) anchor protein 11 |
|
affects expression |
EXP |
15 |
59,649,461 |
59,679,551 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
affects abundance |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
affects response to substance |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
affects expression |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
multiple interactions |
ISO |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Alg2 |
ALG2, alpha-1,3/1,6-mannosyltransferase |
|
affects binding |
ISO |
5 |
64,092,017 |
64,096,576 |
RGD:6480464 |
CTD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
multiple interactions |
ISO |
4 |
152,610,283 |
152,657,891 |
RGD:6480464 |
CTD |
| G |
Alpp |
alkaline phosphatase, placental |
|
affects binding |
ISO |
9 |
85,885,336 |
85,888,082 |
RGD:6480464 |
CTD |
| G |
Anxa1 |
annexin A1 |
|
affects activity |
EXP |
1 |
223,478,436 |
223,494,455 |
RGD:6480464 |
CTD |
| G |
Anxa5 |
annexin A5 |
|
multiple interactions |
ISO |
2 |
122,949,210 |
122,979,757 |
RGD:6480464 |
CTD |
| G |
Anxa5 |
annexin A5 |
|
multiple interactions |
ISO |
2 |
122,949,210 |
122,979,757 |
RGD:6480464 |
CTD |
| G |
Apoe |
apolipoprotein E |
|
affects abundance |
ISO |
1 |
79,003,634 |
79,006,387 |
RGD:6480464 |
CTD |
| G |
Apoe |
apolipoprotein E |
|
affects expression |
EXP |
1 |
79,003,634 |
79,006,387 |
RGD:6480464 |
CTD |
| G |
Apom |
apolipoprotein M |
|
affects expression |
EXP |
20 |
3,754,604 |
3,757,204 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
multiple interactions |
ISO |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
affects abundance |
ISO |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
increases uptake |
EXP |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
multiple interactions |
EXP |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
multiple interactions |
EXP |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
increases uptake |
EXP |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
Arrb2 |
arrestin, beta 2 |
|
multiple interactions |
EXP |
10 |
57,244,071 |
57,284,166 |
RGD:6480464 |
CTD |
| G |
Arrb2 |
arrestin, beta 2 |
|
multiple interactions |
ISO |
10 |
57,244,071 |
57,284,166 |
RGD:6480464 |
CTD |
| G |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
|
multiple interactions |
EXP |
2 |
196,657,749 |
196,687,242 |
RGD:6480464 |
CTD |
| G |
Atp1b1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
|
multiple interactions |
EXP |
13 |
80,214,056 |
80,234,576 |
RGD:6480464 |
CTD |
| G |
Atp2a1 |
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 |
|
affects transport |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Atp2a1 |
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
affects abundance |
ISO |
12 |
35,266,600 |
35,316,237 |
RGD:6480464 |
CTD |
| G |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
affects export |
ISO |
12 |
35,266,600 |
35,316,237 |
RGD:6480464 |
CTD |
| G |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
affects uptake |
ISO |
12 |
35,266,600 |
35,316,237 |
RGD:6480464 |
CTD |
| G |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
multiple interactions |
ISO |
12 |
35,266,600 |
35,316,237 |
RGD:6480464 |
CTD |
| G |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
multiple interactions |
EXP |
12 |
35,266,600 |
35,316,237 |
RGD:6480464 |
CTD |
| G |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
affects transport |
EXP |
12 |
35,266,600 |
35,316,237 |
RGD:6480464 |
CTD |
| G |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
multiple interactions |
EXP |
12 |
35,266,600 |
35,316,237 |
RGD:6480464 |
CTD |
| G |
Atp2b1 |
ATPase, Ca++ transporting, plasma membrane 1 |
|
multiple interactions |
ISO |
7 |
36,493,661 |
36,600,280 |
RGD:6480464 |
CTD |
| G |
Atp2b1 |
ATPase, Ca++ transporting, plasma membrane 1 |
|
increases export |
ISO |
7 |
36,493,661 |
36,600,280 |
RGD:6480464 |
CTD |
| G |
Atp2b4 |
ATPase, Ca++ transporting, plasma membrane 4 |
|
increases export |
ISO |
13 |
46,631,205 |
46,697,214 |
RGD:6480464 |
CTD |
| G |
Atp2b4 |
ATPase, Ca++ transporting, plasma membrane 4 |
|
multiple interactions |
ISO |
13 |
46,631,205 |
46,697,214 |
RGD:6480464 |
CTD |
| G |
Atp8b1 |
ATPase, aminophospholipid transporter, class I, type 8B, member 1 |
|
multiple interactions |
EXP |
18 |
60,748,738 |
60,829,650 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
multiple interactions |
EXP |
3 |
118,205,007 |
118,206,985 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
multiple interactions |
EXP |
3 |
118,205,007 |
118,206,985 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
multiple interactions |
EXP |
3 |
118,205,007 |
118,206,985 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
increases abundance |
EXP |
3 |
118,205,007 |
118,206,985 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
increases abundance |
EXP |
3 |
118,205,007 |
118,206,985 |
RGD:6480464 |
CTD |
| G |
Avpr1a |
arginine vasopressin receptor 1A |
|
multiple interactions |
EXP |
7 |
62,225,537 |
62,229,461 |
RGD:6480464 |
CTD |
| G |
Avpr1a |
arginine vasopressin receptor 1A |
|
multiple interactions |
EXP |
7 |
62,225,537 |
62,229,461 |
RGD:6480464 |
CTD |
| G |
Avpr2 |
arginine vasopressin receptor 2 |
|
affects expression |
EXP |
X |
159,821,860 |
159,823,488 |
RGD:6480464 |
CTD |
| G |
Axin1 |
axin 1 |
|
affects expression |
EXP |
10 |
15,409,373 |
15,462,726 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
affects expression |
EXP |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bdkrb1 |
bradykinin receptor B1 |
|
multiple interactions |
ISO |
6 |
129,760,129 |
129,762,545 |
RGD:6480464 |
CTD |
| G |
Bdkrb1 |
bradykinin receptor B1 |
|
multiple interactions |
EXP |
6 |
129,760,129 |
129,762,545 |
RGD:6480464 |
CTD |
| G |
Bdkrb2 |
bradykinin receptor B2 |
|
multiple interactions |
ISO |
6 |
129,744,781 |
129,748,851 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Best1 |
bestrophin 1 |
|
increases activity |
ISO |
1 |
212,432,811 |
212,449,374 |
RGD:6480464 |
CTD |
| G |
Best1 |
bestrophin 1 |
|
multiple interactions |
ISO |
1 |
212,432,811 |
212,449,374 |
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
affects expression |
EXP |
15 |
22,283,171 |
22,286,757 |
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
multiple interactions |
ISO |
15 |
22,283,171 |
22,286,757 |
RGD:6480464 |
CTD |
| G |
Btk |
Bruton agammaglobulinemia tyrosine kinase |
|
affects transport |
ISO |
X |
121,998,935 |
122,030,289 |
RGD:6480464 |
CTD |
| G |
C5 |
complement component 5 |
|
multiple interactions |
ISO |
3 |
14,011,115 |
14,102,744 |
RGD:6480464 |
CTD |
| G |
C5 |
complement component 5 |
|
multiple interactions |
ISO |
3 |
14,011,115 |
14,102,744 |
RGD:6480464 |
CTD |
| G |
Cacna1a |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
|
increases transport |
EXP |
19 |
25,188,170 |
25,424,495 |
RGD:6480464 |
CTD |
| G |
Cacna1a |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
|
multiple interactions |
EXP |
19 |
25,188,170 |
25,424,495 |
RGD:6480464 |
CTD |
| G |
Cacna1b |
calcium channel, voltage-dependent, N type, alpha 1B subunit |
|
multiple interactions |
EXP |
3 |
2,842,948 |
3,039,747 |
RGD:6480464 |
CTD |
| G |
Cacna1b |
calcium channel, voltage-dependent, N type, alpha 1B subunit |
|
increases transport |
EXP |
3 |
2,842,948 |
3,039,747 |
RGD:6480464 |
CTD |
| G |
Cacna1b |
calcium channel, voltage-dependent, N type, alpha 1B subunit |
|
decreases uptake |
EXP |
3 |
2,842,948 |
3,039,747 |
RGD:6480464 |
CTD |
| G |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
|
multiple interactions |
ISO |
4 |
154,895,691 |
155,517,389 |
RGD:6480464 |
CTD |
| G |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
|
increases transport |
ISO |
4 |
154,895,691 |
155,517,389 |
RGD:6480464 |
CTD |
| G |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
|
increases transport |
EXP |
4 |
154,895,691 |
155,517,389 |
RGD:6480464 |
CTD |
| G |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
|
multiple interactions |
EXP |
4 |
154,895,691 |
155,517,389 |
RGD:6480464 |
CTD |
| G |
Cacna1d |
calcium channel, voltage-dependent, L type, alpha 1D subunit |
|
multiple interactions |
EXP |
16 |
5,383,259 |
5,703,361 |
RGD:6480464 |
CTD |
| G |
Cacna1d |
calcium channel, voltage-dependent, L type, alpha 1D subunit |
|
affects transport |
ISO |
16 |
5,383,259 |
5,703,361 |
RGD:6480464 |
CTD |
| G |
Cacna1d |
calcium channel, voltage-dependent, L type, alpha 1D subunit |
|
multiple interactions |
EXP |
16 |
5,383,259 |
5,703,361 |
RGD:6480464 |
CTD |
| G |
Cacna1e |
calcium channel, voltage-dependent, R type, alpha 1E subunit |
|
multiple interactions |
EXP |
13 |
69,367,254 |
69,683,943 |
RGD:6480464 |
CTD |
| G |
Cacna1e |
calcium channel, voltage-dependent, R type, alpha 1E subunit |
|
increases transport |
ISO |
13 |
69,367,254 |
69,683,943 |
RGD:6480464 |
CTD |
| G |
Cacna1e |
calcium channel, voltage-dependent, R type, alpha 1E subunit |
|
multiple interactions |
ISO |
13 |
69,367,254 |
69,683,943 |
RGD:6480464 |
CTD |
| G |
Cacna1e |
calcium channel, voltage-dependent, R type, alpha 1E subunit |
|
increases transport |
EXP |
13 |
69,367,254 |
69,683,943 |
RGD:6480464 |
CTD |
| G |
Cacna1e |
calcium channel, voltage-dependent, R type, alpha 1E subunit |
|
increases transport |
EXP |
13 |
69,367,254 |
69,683,943 |
RGD:6480464 |
CTD |
| G |
Cacna1f |
calcium channel, voltage-dependent, L type, alpha 1F subunit |
|
increases transport |
ISO |
X |
26,908,850 |
26,937,165 |
RGD:6480464 |
CTD |
| G |
Cacna1g |
calcium channel, voltage-dependent, T type, alpha 1G subunit |
|
increases transport |
EXP |
10 |
83,043,636 |
83,112,886 |
RGD:6480464 |
CTD |
| G |
Cacna1g |
calcium channel, voltage-dependent, T type, alpha 1G subunit |
|
increases transport |
ISO |
10 |
83,043,636 |
83,112,886 |
RGD:6480464 |
CTD |
| G |
Cacna1g |
calcium channel, voltage-dependent, T type, alpha 1G subunit |
|
multiple interactions |
ISO |
10 |
83,043,636 |
83,112,886 |
RGD:6480464 |
CTD |
| G |
Cacna1g |
calcium channel, voltage-dependent, T type, alpha 1G subunit |
|
multiple interactions |
EXP |
10 |
83,043,636 |
83,112,886 |
RGD:6480464 |
CTD |
| G |
Cacna1g |
calcium channel, voltage-dependent, T type, alpha 1G subunit |
|
increases transport |
EXP |
10 |
83,043,636 |
83,112,886 |
RGD:6480464 |
CTD |
| G |
Cacna1h |
calcium channel, voltage-dependent, T type, alpha 1H subunit |
|
increases transport |
ISO |
10 |
14,621,372 |
14,679,051 |
RGD:6480464 |
CTD |
| G |
Cacna1h |
calcium channel, voltage-dependent, T type, alpha 1H subunit |
|
multiple interactions |
ISO |
10 |
14,621,372 |
14,679,051 |
RGD:6480464 |
CTD |
| G |
Cacna1h |
calcium channel, voltage-dependent, T type, alpha 1H subunit |
|
multiple interactions |
ISO |
10 |
14,621,372 |
14,679,051 |
RGD:6480464 |
CTD |
| G |
Cacna1h |
calcium channel, voltage-dependent, T type, alpha 1H subunit |
|
increases transport |
ISO |
10 |
14,621,372 |
14,679,051 |
RGD:6480464 |
CTD |
| G |
Cacna1h |
calcium channel, voltage-dependent, T type, alpha 1H subunit |
|
increases transport |
EXP |
10 |
14,621,372 |
14,679,051 |
RGD:6480464 |
CTD |
| G |
Cacna1i |
calcium channel, voltage-dependent, T type, alpha 1I subunit |
|
increases transport |
EXP |
7 |
118,582,279 |
118,681,537 |
RGD:6480464 |
CTD |
| G |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
|
multiple interactions |
ISO |
4 |
15,139,881 |
15,566,740 |
RGD:6480464 |
CTD |
| G |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
|
multiple interactions |
ISO |
4 |
15,139,881 |
15,566,740 |
RGD:6480464 |
CTD |
| G |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
|
increases transport |
EXP |
4 |
15,139,881 |
15,566,740 |
RGD:6480464 |
CTD |
| G |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
|
multiple interactions |
EXP |
4 |
15,139,881 |
15,566,740 |
RGD:6480464 |
CTD |
| G |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
|
increases transport |
EXP |
4 |
15,139,881 |
15,566,740 |
RGD:6480464 |
CTD |
| G |
Cacna2d2 |
calcium channel, voltage-dependent, alpha 2/delta subunit 2 |
|
affects transport |
ISO |
8 |
112,643,409 |
112,775,460 |
RGD:6480464 |
CTD |
| G |
Cacna2d4 |
calcium channel, voltage-dependent, alpha 2/delta subunit 4 |
|
multiple interactions |
ISO |
4 |
155,546,301 |
155,658,429 |
RGD:6480464 |
CTD |
| G |
Cacnb3 |
calcium channel, voltage-dependent, beta 3 subunit |
|
multiple interactions |
ISO |
7 |
137,384,752 |
137,394,283 |
RGD:6480464 |
CTD |
| G |
Cacnb3 |
calcium channel, voltage-dependent, beta 3 subunit |
|
multiple interactions |
EXP |
7 |
137,384,752 |
137,394,283 |
RGD:6480464 |
CTD |
| G |
Cacng2 |
calcium channel, voltage-dependent, gamma subunit 2 |
|
multiple interactions |
ISO |
7 |
115,913,440 |
116,037,891 |
RGD:6480464 |
CTD |
| G |
Cacng4 |
calcium channel, voltage-dependent, gamma subunit 4 |
|
multiple interactions |
ISO |
10 |
97,139,397 |
97,214,444 |
RGD:6480464 |
CTD |
| G |
Cacng5 |
calcium channel, voltage-dependent, gamma subunit 5 |
|
multiple interactions |
ISO |
10 |
97,300,594 |
97,309,023 |
RGD:6480464 |
CTD |
| G |
Calb1 |
calbindin 1 |
|
affects expression |
EXP |
5 |
30,455,665 |
30,480,122 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
increases expression |
ISO |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
multiple interactions |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
multiple interactions |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
multiple interactions |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
increases expression |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calm1 |
calmodulin 1 |
|
multiple interactions |
ISO |
6 |
124,477,601 |
124,485,669 |
RGD:6480464 |
CTD |
| G |
Calm1 |
calmodulin 1 |
|
multiple interactions |
EXP |
6 |
124,477,601 |
124,485,669 |
RGD:6480464 |
CTD |
| G |
Calm1 |
calmodulin 1 |
|
multiple interactions |
EXP |
6 |
124,477,601 |
124,485,669 |
RGD:6480464 |
CTD |
| G |
Calm1 |
calmodulin 1 |
|
affects binding |
EXP |
6 |
124,477,601 |
124,485,669 |
RGD:6480464 |
CTD |
| G |
Calr |
calreticulin |
|
affects response to substance |
ISO |
19 |
24,964,775 |
24,969,670 |
RGD:6480464 |
CTD |
| G |
Calr |
calreticulin |
|
multiple interactions |
ISO |
19 |
24,964,775 |
24,969,670 |
RGD:6480464 |
CTD |
| G |
Camk2d |
calcium/calmodulin-dependent protein kinase II delta |
|
affects expression |
EXP |
2 |
223,840,650 |
224,108,082 |
RGD:6480464 |
CTD |
| G |
Capn1 |
calpain 1, (mu/I) large subunit |
|
multiple interactions |
ISO |
1 |
208,620,286 |
208,645,007 |
RGD:6480464 |
CTD |
| G |
Capn1 |
calpain 1, (mu/I) large subunit |
|
multiple interactions |
ISO |
1 |
208,620,286 |
208,645,007 |
RGD:6480464 |
CTD |
| G |
Car4 |
carbonic anhydrase 4 |
|
affects expression |
EXP |
10 |
73,229,211 |
73,237,707 |
RGD:6480464 |
CTD |
| G |
Casr |
calcium-sensing receptor |
|
multiple interactions |
ISO |
11 |
66,084,169 |
66,153,292 |
RGD:6480464 |
CTD |
| G |
Casr |
calcium-sensing receptor |
|
increases activity |
ISO |
11 |
66,084,169 |
66,153,292 |
RGD:6480464 |
CTD |
| G |
Casr |
calcium-sensing receptor |
|
multiple interactions |
ISO |
11 |
66,084,169 |
66,153,292 |
RGD:6480464 |
CTD |
| G |
Casr |
calcium-sensing receptor |
|
increases uptake |
ISO |
11 |
66,084,169 |
66,153,292 |
RGD:6480464 |
CTD |
| G |
Casr |
calcium-sensing receptor |
|
multiple interactions |
ISO |
11 |
66,084,169 |
66,153,292 |
RGD:6480464 |
CTD |
| G |
Casr |
calcium-sensing receptor |
|
increases phosphorylation |
ISO |
11 |
66,084,169 |
66,153,292 |
RGD:6480464 |
CTD |
| G |
Casr |
calcium-sensing receptor |
|
increases response to substance |
ISO |
11 |
66,084,169 |
66,153,292 |
RGD:6480464 |
CTD |
| G |
Casr |
calcium-sensing receptor |
|
decreases response to substance |
ISO |
11 |
66,084,169 |
66,153,292 |
RGD:6480464 |
CTD |
| G |
Casr |
calcium-sensing receptor |
|
increases response to substance |
ISO |
11 |
66,084,169 |
66,153,292 |
RGD:6480464 |
CTD |
| G |
Casr |
calcium-sensing receptor |
|
multiple interactions |
ISO |
11 |
66,084,169 |
66,153,292 |
RGD:6480464 |
CTD |
| G |
Casr |
calcium-sensing receptor |
|
multiple interactions |
ISO |
11 |
66,084,169 |
66,153,292 |
RGD:6480464 |
CTD |
| G |
Casr |
calcium-sensing receptor |
|
affects expression |
EXP |
11 |
66,084,169 |
66,153,292 |
RGD:6480464 |
CTD |
| G |
Casr |
calcium-sensing receptor |
|
multiple interactions |
EXP |
11 |
66,084,169 |
66,153,292 |
RGD:6480464 |
CTD |
| G |
Casr |
calcium-sensing receptor |
|
multiple interactions |
ISO |
11 |
66,084,169 |
66,153,292 |
RGD:6480464 |
CTD |
| G |
Casr |
calcium-sensing receptor |
|
increases response to substance |
ISO |
11 |
66,084,169 |
66,153,292 |
RGD:6480464 |
CTD |
| G |
Casr |
calcium-sensing receptor |
|
multiple interactions |
EXP |
11 |
66,084,169 |
66,153,292 |
RGD:6480464 |
CTD |
| G |
Casr |
calcium-sensing receptor |
|
multiple interactions |
EXP |
11 |
66,084,169 |
66,153,292 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
affects transport |
ISO |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Cav3 |
caveolin 3 |
|
multiple interactions |
ISO |
4 |
148,294,428 |
148,310,380 |
RGD:6480464 |
CTD |
| G |
Cbfb |
core-binding factor, beta subunit |
|
affects expression |
EXP |
19 |
34,985,879 |
35,029,446 |
RGD:6480464 |
CTD |
| G |
Ccl11 |
chemokine (C-C motif) ligand 11 |
|
increases uptake |
ISO |
10 |
70,279,161 |
70,283,762 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases uptake |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases abundance |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
multiple interactions |
ISO |
10 |
71,744,559 |
71,746,109 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
increases uptake |
ISO |
10 |
71,605,791 |
71,610,330 |
RGD:6480464 |
CTD |
| G |
Ccl7 |
chemokine (C-C motif) ligand 7 |
|
increases uptake |
ISO |
10 |
70,267,281 |
70,269,131 |
RGD:6480464 |
CTD |
| G |
Ccl7 |
chemokine (C-C motif) ligand 7 |
|
multiple interactions |
ISO |
10 |
70,267,281 |
70,269,131 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
affects expression |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccr10 |
chemokine (C-C motif) receptor 10 |
|
affects abundance |
ISO |
10 |
90,193,776 |
90,196,213 |
RGD:6480464 |
CTD |
| G |
Ccr4 |
chemokine (C-C motif) receptor 4 |
|
affects abundance |
ISO |
8 |
118,883,148 |
118,884,230 |
RGD:6480464 |
CTD |
| G |
Ccr8 |
chemokine (C-C motif) receptor 8 |
|
affects abundance |
ISO |
8 |
125,075,457 |
125,076,518 |
RGD:6480464 |
CTD |
| G |
Ccr9 |
chemokine (C-C motif) receptor 9 |
|
affects abundance |
ISO |
8 |
128,527,943 |
128,541,982 |
RGD:6480464 |
CTD |
| G |
Cd28 |
Cd28 molecule |
|
multiple interactions |
ISO |
9 |
59,342,273 |
59,367,743 |
RGD:6480464 |
CTD |
| G |
Cd28 |
Cd28 molecule |
|
increases abundance |
ISO |
9 |
59,342,273 |
59,367,743 |
RGD:6480464 |
CTD |
| G |
Cd38 |
CD38 molecule |
|
multiple interactions |
ISO |
14 |
72,320,479 |
72,360,329 |
RGD:6480464 |
CTD |
| G |
Cd38 |
CD38 molecule |
|
multiple interactions |
ISO |
14 |
72,320,479 |
72,360,329 |
RGD:6480464 |
CTD |
| G |
Cdc42 |
cell division cycle 42 (GTP binding protein) |
|
multiple interactions |
ISO |
5 |
156,106,123 |
156,143,040 |
RGD:6480464 |
CTD |
| G |
Cdc42bpb |
CDC42 binding protein kinase beta (DMPK-like) |
|
affects expression |
EXP |
6 |
136,053,885 |
136,136,234 |
RGD:6480464 |
CTD |
| G |
Cdk5r1 |
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
|
multiple interactions |
ISO |
10 |
68,715,844 |
68,717,045 |
RGD:6480464 |
CTD |
| G |
Cdk5r1 |
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
|
increases cleavage |
ISO |
10 |
68,715,844 |
68,717,045 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
affects expression |
EXP |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Cerk |
ceramide kinase |
|
multiple interactions |
ISO |
7 |
124,139,137 |
124,182,070 |
RGD:6480464 |
CTD |
| G |
Cfb |
complement factor B |
|
multiple interactions |
ISO |
20 |
4,072,124 |
4,077,802 |
RGD:6480464 |
CTD |
| G |
Cfd |
complement factor D (adipsin) |
|
multiple interactions |
ISO |
7 |
11,325,538 |
11,327,261 |
RGD:6480464 |
CTD |
| G |
Cfl1 |
cofilin 1, non-muscle |
|
multiple interactions |
ISO |
1 |
208,133,876 |
208,137,408 |
RGD:6480464 |
CTD |
| G |
Chrm1 |
cholinergic receptor, muscarinic 1 |
|
multiple interactions |
ISO |
1 |
211,351,738 |
211,353,120 |
RGD:6480464 |
CTD |
| G |
Chrm1 |
cholinergic receptor, muscarinic 1 |
|
multiple interactions |
ISO |
1 |
211,351,738 |
211,353,120 |
RGD:6480464 |
CTD |
| G |
Chrm1 |
cholinergic receptor, muscarinic 1 |
|
multiple interactions |
ISO |
1 |
211,351,738 |
211,353,120 |
RGD:6480464 |
CTD |
| G |
Chrm1 |
cholinergic receptor, muscarinic 1 |
|
multiple interactions |
EXP |
1 |
211,351,738 |
211,353,120 |
RGD:6480464 |
CTD |
| G |
Chrna4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal) |
|
multiple interactions |
EXP |
3 |
170,171,214 |
170,185,998 |
RGD:6480464 |
CTD |
| G |
Chrna7 |
cholinergic receptor, nicotinic, alpha 7 (neuronal) |
|
multiple interactions |
ISO |
1 |
117,587,580 |
117,716,267 |
RGD:6480464 |
CTD |
| G |
Chrna7 |
cholinergic receptor, nicotinic, alpha 7 (neuronal) |
|
multiple interactions |
ISO |
1 |
117,587,580 |
117,716,267 |
RGD:6480464 |
CTD |
| G |
Chrna7 |
cholinergic receptor, nicotinic, alpha 7 (neuronal) |
|
multiple interactions |
ISO |
1 |
117,587,580 |
117,716,267 |
RGD:6480464 |
CTD |
| G |
Chrna7 |
cholinergic receptor, nicotinic, alpha 7 (neuronal) |
|
multiple interactions |
EXP |
1 |
117,587,580 |
117,716,267 |
RGD:6480464 |
CTD |
| G |
Chrnb2 |
cholinergic receptor, nicotinic, beta 2 (neuronal) |
|
multiple interactions |
ISO |
2 |
181,961,373 |
181,969,581 |
RGD:6480464 |
CTD |
| G |
Chrnb2 |
cholinergic receptor, nicotinic, beta 2 (neuronal) |
|
multiple interactions |
EXP |
2 |
181,961,373 |
181,969,581 |
RGD:6480464 |
CTD |
| G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
affects expression |
EXP |
1 |
12,721,500 |
12,723,943 |
RGD:6480464 |
CTD |
| G |
Cnnm4 |
cyclin M4 |
|
affects expression |
EXP |
9 |
35,410,644 |
35,448,730 |
RGD:6480464 |
CTD |
| G |
Cnr1 |
cannabinoid receptor 1 (brain) |
|
multiple interactions |
EXP |
5 |
50,427,173 |
50,445,471 |
RGD:6480464 |
CTD |
| G |
Cnr1 |
cannabinoid receptor 1 (brain) |
|
multiple interactions |
EXP |
5 |
50,427,173 |
50,445,471 |
RGD:6480464 |
CTD |
| G |
Cnr1 |
cannabinoid receptor 1 (brain) |
|
multiple interactions |
EXP |
5 |
50,427,173 |
50,445,471 |
RGD:6480464 |
CTD |
| G |
Cnr2 |
cannabinoid receptor 2 (macrophage) |
|
multiple interactions |
ISO |
5 |
154,674,754 |
154,702,552 |
RGD:6480464 |
CTD |
| G |
Col18a1 |
collagen, type XVIII, alpha 1 |
|
affects abundance |
ISO |
20 |
11,920,816 |
11,982,468 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
affects abundance |
ISO |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Cp |
ceruloplasmin (ferroxidase) |
|
affects binding |
ISO |
2 |
105,086,278 |
105,135,367 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
affects expression |
EXP |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
EXP |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
EXP |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Csnk1a1 |
casein kinase 1, alpha 1 |
|
affects expression |
EXP |
18 |
57,541,673 |
57,564,560 |
RGD:6480464 |
CTD |
| G |
Csnk1g3 |
casein kinase 1, gamma 3 |
|
affects expression |
EXP |
18 |
49,369,579 |
49,451,893 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases abundance |
EXP |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
EXP |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
increases uptake |
ISO |
4 |
153,503,576 |
153,516,423 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
multiple interactions |
ISO |
4 |
153,503,576 |
153,516,423 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
increases uptake |
ISO |
4 |
153,503,576 |
153,516,423 |
RGD:6480464 |
CTD |
| G |
Cxcl9 |
chemokine (C-X-C motif) ligand 9 |
|
multiple interactions |
ISO |
14 |
17,284,085 |
17,288,996 |
RGD:6480464 |
CTD |
| G |
Cxcl9 |
chemokine (C-X-C motif) ligand 9 |
|
increases abundance |
ISO |
14 |
17,284,085 |
17,288,996 |
RGD:6480464 |
CTD |
| G |
Cxcr1 |
chemokine (C-X-C motif) receptor 1 |
|
multiple interactions |
ISO |
9 |
73,510,488 |
73,511,537 |
RGD:6480464 |
CTD |
| G |
Cxcr1 |
chemokine (C-X-C motif) receptor 1 |
|
affects abundance |
ISO |
9 |
73,510,488 |
73,511,537 |
RGD:6480464 |
CTD |
| G |
Cxcr2 |
chemokine (C-X-C motif) receptor 2 |
|
affects transport |
ISO |
9 |
73,470,943 |
73,477,315 |
RGD:6480464 |
CTD |
| G |
Cxcr2 |
chemokine (C-X-C motif) receptor 2 |
|
multiple interactions |
ISO |
9 |
73,470,943 |
73,477,315 |
RGD:6480464 |
CTD |
| G |
Cxcr2 |
chemokine (C-X-C motif) receptor 2 |
|
multiple interactions |
ISO |
9 |
73,470,943 |
73,477,315 |
RGD:6480464 |
CTD |
| G |
Cxcr3 |
chemokine (C-X-C motif) receptor 3 |
|
affects abundance |
ISO |
X |
89,794,276 |
89,796,927 |
RGD:6480464 |
CTD |
| G |
Cxcr3 |
chemokine (C-X-C motif) receptor 3 |
|
multiple interactions |
ISO |
X |
89,794,276 |
89,796,927 |
RGD:6480464 |
CTD |
| G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
affects abundance |
ISO |
13 |
41,308,286 |
41,312,190 |
RGD:6480464 |
CTD |
| G |
Cxcr5 |
chemokine (C-X-C motif) receptor 5 |
|
affects abundance |
ISO |
8 |
47,485,125 |
47,498,509 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
multiple interactions |
EXP |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
decreases secretion |
EXP |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
multiple interactions |
EXP |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
increases secretion |
EXP |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
multiple interactions |
EXP |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
multiple interactions |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
multiple interactions |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
|
affects expression |
EXP |
3 |
161,542,131 |
161,553,801 |
RGD:6480464 |
CTD |
| G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
3 |
161,542,131 |
161,553,801 |
RGD:6480464 |
CTD |
| G |
Cyp27b1 |
cytochrome P450, family 27, subfamily b, polypeptide 1 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
affects expression |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
decreases uptake |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr2 |
cysteinyl leukotriene receptor 2 |
|
multiple interactions |
ISO |
15 |
53,647,500 |
53,648,429 |
RGD:6480464 |
CTD |
| G |
Cysltr2 |
cysteinyl leukotriene receptor 2 |
|
multiple interactions |
ISO |
15 |
53,647,500 |
53,648,429 |
RGD:6480464 |
CTD |
| G |
Ddr1 |
discoidin domain receptor tyrosine kinase 1 |
|
affects expression |
EXP |
20 |
3,194,265 |
3,214,611 |
RGD:6480464 |
CTD |
| G |
Drd1 |
dopamine receptor D1 |
|
multiple interactions |
EXP |
17 |
16,655,926 |
16,658,161 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
multiple interactions |
ISO |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
multiple interactions |
EXP |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd3 |
dopamine receptor D3 |
|
increases phosphorylation |
EXP |
11 |
58,446,901 |
58,520,589 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
multiple interactions |
EXP |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
multiple interactions |
ISO |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
affects transport |
ISO |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
multiple interactions |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
multiple interactions |
ISO |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
increases uptake |
ISO |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
multiple interactions |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
increases abundance |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
multiple interactions |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
affects localization |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn2 |
endothelin 2 |
|
increases uptake |
ISO |
5 |
140,742,686 |
140,747,580 |
RGD:6480464 |
CTD |
| G |
Edn2 |
endothelin 2 |
|
multiple interactions |
ISO |
5 |
140,742,686 |
140,747,580 |
RGD:6480464 |
CTD |
| G |
Edn3 |
endothelin 3 |
|
multiple interactions |
ISO |
3 |
166,491,368 |
166,514,051 |
RGD:6480464 |
CTD |
| G |
Edn3 |
endothelin 3 |
|
increases uptake |
ISO |
3 |
166,491,368 |
166,514,051 |
RGD:6480464 |
CTD |
| G |
Edn3 |
endothelin 3 |
|
multiple interactions |
EXP |
3 |
166,491,368 |
166,514,051 |
RGD:6480464 |
CTD |
| G |
Edn3 |
endothelin 3 |
|
multiple interactions |
EXP |
3 |
166,491,368 |
166,514,051 |
RGD:6480464 |
CTD |
| G |
Ednra |
endothelin receptor type A |
|
affects activity |
EXP |
19 |
32,042,366 |
32,108,153 |
RGD:6480464 |
CTD |
| G |
Eef2 |
eukaryotic translation elongation factor 2 |
|
multiple interactions |
EXP |
7 |
10,017,061 |
10,022,331 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
increases abundance |
ISO |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
ISO |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
ISO |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
affects expression |
EXP |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
EXP |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
multiple interactions |
EXP |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
multiple interactions |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Eif4a2 |
eukaryotic translation initiation factor 4A2 |
|
multiple interactions |
EXP |
11 |
79,950,592 |
79,957,185 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
multiple interactions |
EXP |
16 |
69,110,522 |
69,123,895 |
RGD:6480464 |
CTD |
| G |
Ephx2 |
epoxide hydrolase 2, cytoplasmic |
|
affects expression |
EXP |
15 |
45,497,660 |
45,556,101 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
multiple interactions |
ISO |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
increases abundance |
ISO |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
F2r |
coagulation factor II (thrombin) receptor |
|
multiple interactions |
ISO |
2 |
25,985,800 |
25,989,072 |
RGD:6480464 |
CTD |
| G |
F2rl1 |
coagulation factor II (thrombin) receptor-like 1 |
|
multiple interactions |
ISO |
2 |
25,886,177 |
25,899,128 |
RGD:6480464 |
CTD |
| G |
F8 |
coagulation factor VIII, procoagulant component |
|
multiple interactions |
ISO |
18 |
121,134 |
162,008 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
multiple interactions |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
affects localization |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Fgf1 |
fibroblast growth factor 1 (acidic) |
|
increases expression |
EXP |
18 |
31,785,480 |
31,806,452 |
RGD:6480464 |
CTD |
| G |
Fgf23 |
fibroblast growth factor 23 |
|
affects expression |
ISO |
4 |
163,468,604 |
163,476,325 |
RGD:6480464 |
CTD |
| G |
Fgf23 |
fibroblast growth factor 23 |
|
affects expression |
ISO |
4 |
163,468,604 |
163,476,325 |
RGD:6480464 |
CTD |
| G |
Fgf9 |
fibroblast growth factor 9 |
|
affects expression |
EXP |
15 |
37,115,068 |
37,155,652 |
RGD:6480464 |
CTD |
| G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
multiple interactions |
EXP |
16 |
70,869,974 |
70,910,045 |
RGD:6480464 |
CTD |
| G |
Fis1 |
fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae) |
|
affects expression |
EXP |
12 |
20,806,840 |
20,821,766 |
RGD:6480464 |
CTD |
| G |
Fkbp1a |
FK506 binding protein 1a |
|
multiple interactions |
ISO |
3 |
141,861,237 |
141,880,797 |
RGD:6480464 |
CTD |
| G |
Fkbp1b |
FK506 binding protein 1b |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Furin |
furin (paired basic amino acid cleaving enzyme) |
|
affects expression |
EXP |
1 |
136,209,969 |
136,222,057 |
RGD:6480464 |
CTD |
| G |
Fxyd2 |
FXYD domain-containing ion transport regulator 2 |
|
multiple interactions |
ISO |
8 |
48,379,075 |
48,385,553 |
RGD:6480464 |
CTD |
| G |
Fxyd2 |
FXYD domain-containing ion transport regulator 2 |
|
decreases activity |
ISO |
8 |
48,379,075 |
48,385,553 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
affects expression |
EXP |
10 |
90,393,531 |
90,403,485 |
RGD:6480464 |
CTD |
| G |
Gabbr1 |
gamma-aminobutyric acid (GABA) B receptor 1 |
|
multiple interactions |
ISO |
20 |
1,553,297 |
1,582,426 |
RGD:6480464 |
CTD |
| G |
Gabbr1 |
gamma-aminobutyric acid (GABA) B receptor 1 |
|
affects expression |
EXP |
20 |
1,553,297 |
1,582,426 |
RGD:6480464 |
CTD |
| G |
Gabbr2 |
gamma-aminobutyric acid (GABA) B receptor 2 |
|
multiple interactions |
ISO |
5 |
63,241,397 |
63,611,907 |
RGD:6480464 |
CTD |
| G |
Gast |
gastrin |
|
multiple interactions |
ISO |
10 |
89,273,628 |
89,276,192 |
RGD:6480464 |
CTD |
| G |
Gata1 |
GATA binding protein 1 |
|
affects expression |
EXP |
X |
26,564,259 |
26,572,081 |
RGD:6480464 |
CTD |
| G |
Gc |
group specific component |
|
affects expression |
EXP |
14 |
20,166,243 |
20,197,060 |
RGD:6480464 |
CTD |
| G |
Gcg |
glucagon |
|
multiple interactions |
EXP |
3 |
44,433,180 |
44,438,004 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
multiple interactions |
EXP |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
multiple interactions |
EXP |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
multiple interactions |
EXP |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Ghr |
growth hormone receptor |
|
affects expression |
EXP |
2 |
52,496,517 |
52,658,066 |
RGD:6480464 |
CTD |
| G |
Ghr |
growth hormone receptor |
|
multiple interactions |
EXP |
2 |
52,496,517 |
52,658,066 |
RGD:6480464 |
CTD |
| G |
Glrx3 |
glutaredoxin 3 |
|
affects response to substance |
EXP |
1 |
197,176,020 |
197,206,249 |
RGD:6480464 |
CTD |
| G |
Gnai2 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
|
affects expression |
EXP |
8 |
112,861,952 |
112,882,647 |
RGD:6480464 |
CTD |
| G |
Grm1 |
glutamate receptor, metabotropic 1 |
|
multiple interactions |
EXP |
1 |
5,318,617 |
5,744,593 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
multiple interactions |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hes1 |
hairy and enhancer of split 1 (Drosophila) |
|
affects expression |
EXP |
11 |
72,603,482 |
72,605,673 |
RGD:6480464 |
CTD |
| G |
Hgf |
hepatocyte growth factor |
|
increases abundance |
EXP |
4 |
14,864,357 |
14,932,513 |
RGD:6480464 |
CTD |
| G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) |
|
affects expression |
EXP |
2 |
193,128,736 |
193,143,106 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
|
affects expression |
EXP |
3 |
154,459,863 |
154,482,825 |
RGD:6480464 |
CTD |
| G |
Homer1 |
homer homolog 1 (Drosophila) |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Hpca |
hippocalcin |
|
decreases response to substance |
ISO |
5 |
148,267,898 |
148,276,223 |
RGD:6480464 |
CTD |
| G |
Hrh1 |
histamine receptor H 1 |
|
multiple interactions |
ISO |
4 |
150,431,239 |
150,432,699 |
RGD:6480464 |
CTD |
| G |
Hrh1 |
histamine receptor H 1 |
|
multiple interactions |
ISO |
4 |
150,431,239 |
150,432,699 |
RGD:6480464 |
CTD |
| G |
Hrh1 |
histamine receptor H 1 |
|
increases abundance |
ISO |
4 |
150,431,239 |
150,432,699 |
RGD:6480464 |
CTD |
| G |
Hrh1 |
histamine receptor H 1 |
|
multiple interactions |
ISO |
4 |
150,431,239 |
150,432,699 |
RGD:6480464 |
CTD |
| G |
Hrh3 |
histamine receptor H3 |
|
multiple interactions |
ISO |
3 |
169,154,980 |
169,160,064 |
RGD:6480464 |
CTD |
| G |
Hrh4 |
histamine receptor H4 |
|
multiple interactions |
ISO |
18 |
4,275,671 |
4,292,259 |
RGD:6480464 |
CTD |
| G |
Hrh4 |
histamine receptor H4 |
|
multiple interactions |
ISO |
18 |
4,275,671 |
4,292,259 |
RGD:6480464 |
CTD |
| G |
Hsd17b12 |
hydroxysteroid (17-beta) dehydrogenase 12 |
|
multiple interactions |
EXP |
3 |
78,436,634 |
78,559,707 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
multiple interactions |
ISO |
6 |
135,413,616 |
135,419,147 |
RGD:6480464 |
CTD |
| G |
Htr2a |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
|
multiple interactions |
EXP |
15 |
55,463,743 |
55,532,293 |
RGD:6480464 |
CTD |
| G |
Htr2b |
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled |
|
multiple interactions |
ISO |
9 |
84,840,026 |
84,852,984 |
RGD:6480464 |
CTD |
| G |
Htr7 |
5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled |
|
multiple interactions |
EXP |
1 |
240,136,279 |
240,260,620 |
RGD:6480464 |
CTD |
| G |
Ift88 |
intraflagellar transport 88 homolog (Chlamydomonas) |
|
multiple interactions |
ISO |
15 |
36,468,007 |
36,560,959 |
RGD:6480464 |
CTD |
| G |
Ift88 |
intraflagellar transport 88 homolog (Chlamydomonas) |
|
increases uptake |
ISO |
15 |
36,468,007 |
36,560,959 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
increases import |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
increases import |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
affects expression |
EXP |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
increases import |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
increases import |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
increases import |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
increases import |
ISO |
1 |
202,906,624 |
202,915,231 |
RGD:6480464 |
CTD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
multiple interactions |
ISO |
1 |
202,906,624 |
202,915,231 |
RGD:6480464 |
CTD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
multiple interactions |
ISO |
1 |
202,906,624 |
202,915,231 |
RGD:6480464 |
CTD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
multiple interactions |
ISO |
1 |
202,906,624 |
202,915,231 |
RGD:6480464 |
CTD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
increases import |
ISO |
1 |
202,906,624 |
202,915,231 |
RGD:6480464 |
CTD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
increases import |
ISO |
1 |
202,906,624 |
202,915,231 |
RGD:6480464 |
CTD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
increases import |
ISO |
1 |
202,906,624 |
202,915,231 |
RGD:6480464 |
CTD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
increases import |
ISO |
1 |
202,906,624 |
202,915,231 |
RGD:6480464 |
CTD |
| G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
|
affects expression |
EXP |
9 |
71,966,877 |
71,994,211 |
RGD:6480464 |
CTD |
| G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
affects expression |
EXP |
9 |
72,003,637 |
72,016,263 |
RGD:6480464 |
CTD |
| G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
decreases degradation |
EXP |
9 |
72,003,637 |
72,016,263 |
RGD:6480464 |
CTD |
| G |
Il11 |
interleukin 11 |
|
multiple interactions |
ISO |
1 |
67,784,584 |
67,795,141 |
RGD:6480464 |
CTD |
| G |
Il11 |
interleukin 11 |
|
increases abundance |
ISO |
1 |
67,784,584 |
67,795,141 |
RGD:6480464 |
CTD |
| G |
Il13 |
interleukin 13 |
|
multiple interactions |
ISO |
10 |
39,093,512 |
39,096,069 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
multiple interactions |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6st |
interleukin 6 signal transducer |
|
multiple interactions |
ISO |
2 |
43,806,301 |
43,842,365 |
RGD:6480464 |
CTD |
| G |
Ilf3 |
interleukin enhancer binding factor 3 |
|
multiple interactions |
ISO |
8 |
20,481,746 |
20,508,850 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Iqgap1 |
IQ motif containing GTPase activating protein 1 |
|
multiple interactions |
ISO |
1 |
136,552,358 |
136,642,545 |
RGD:6480464 |
CTD |
| G |
Itga2 |
integrin, alpha 2 |
|
multiple interactions |
ISO |
2 |
46,967,681 |
47,080,909 |
RGD:6480464 |
CTD |
| G |
Itgb1bp2 |
integrin beta 1 binding protein 2 |
|
multiple interactions |
ISO |
X |
89,520,700 |
89,525,600 |
RGD:6480464 |
CTD |
| G |
Itgb1bp2 |
integrin beta 1 binding protein 2 |
|
multiple interactions |
ISO |
X |
89,520,700 |
89,525,600 |
RGD:6480464 |
CTD |
| G |
Itih1 |
inter-alpha trypsin inhibitor, heavy chain 1 |
|
multiple interactions |
ISO |
16 |
6,364,102 |
6,378,251 |
RGD:6480464 |
CTD |
| G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
|
multiple interactions |
ISO |
4 |
143,705,360 |
144,030,051 |
RGD:6480464 |
CTD |
| G |
Itpr2 |
inositol 1,4,5-trisphosphate receptor, type 2 |
|
multiple interactions |
ISO |
4 |
183,677,606 |
184,066,130 |
RGD:6480464 |
CTD |
| G |
Itpr3 |
inositol 1,4,5-trisphosphate receptor, type 3 |
|
affects expression |
EXP |
20 |
5,292,430 |
5,357,502 |
RGD:6480464 |
CTD |
| G |
Ivl |
involucrin |
|
increases expression |
ISO |
2 |
185,556,271 |
185,558,310 |
RGD:6480464 |
CTD |
| G |
Ivl |
involucrin |
|
multiple interactions |
ISO |
2 |
185,556,271 |
185,558,310 |
RGD:6480464 |
CTD |
| G |
Jak2 |
Janus kinase 2 |
|
multiple interactions |
ISO |
1 |
232,915,995 |
232,974,763 |
RGD:6480464 |
CTD |
| G |
Kcne1 |
potassium voltage-gated channel, Isk-related family, member 1 |
|
increases activity |
ISO |
11 |
32,344,529 |
32,355,189 |
RGD:6480464 |
CTD |
| G |
Kcne1 |
potassium voltage-gated channel, Isk-related family, member 1 |
|
multiple interactions |
ISO |
11 |
32,344,529 |
32,355,189 |
RGD:6480464 |
CTD |
| G |
Kcnh2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
|
multiple interactions |
EXP |
4 |
6,192,644 |
6,224,285 |
RGD:6480464 |
CTD |
| G |
Kcnj11 |
potassium inwardly rectifying channel, subfamily J, member 11 |
|
multiple interactions |
ISO |
1 |
96,614,960 |
96,617,993 |
RGD:6480464 |
CTD |
| G |
Kcnj11 |
potassium inwardly rectifying channel, subfamily J, member 11 |
|
affects abundance |
ISO |
1 |
96,614,960 |
96,617,993 |
RGD:6480464 |
CTD |
| G |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
|
affects abundance |
ISO |
1 |
79,613,736 |
79,628,887 |
RGD:6480464 |
CTD |
| G |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
|
multiple interactions |
ISO |
1 |
79,613,736 |
79,628,887 |
RGD:6480464 |
CTD |
| G |
Kdr |
kinase insert domain receptor |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Kdr |
kinase insert domain receptor |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Kiss1 |
KiSS-1 metastasis-suppressor |
|
multiple interactions |
ISO |
13 |
46,244,786 |
46,247,288 |
RGD:6480464 |
CTD |
| G |
Kiss1r |
KISS1 receptor |
|
multiple interactions |
ISO |
7 |
11,297,840 |
11,301,187 |
RGD:6480464 |
CTD |
| G |
Kl |
Klotho |
|
affects abundance |
ISO |
12 |
3,732,712 |
3,772,371 |
RGD:6480464 |
CTD |
| G |
Klk1 |
kallikrein 1 |
|
decreases activity |
ISO |
1 |
94,624,828 |
94,628,822 |
RGD:6480464 |
CTD |
| G |
Klk8 |
kallikrein related-peptidase 8 |
|
increases activity |
ISO |
1 |
94,227,185 |
94,234,028 |
RGD:6480464 |
CTD |
| G |
Kng1 |
kininogen 1 |
|
multiple interactions |
EXP |
11 |
80,109,499 |
80,131,887 |
RGD:6480464 |
CTD |
| G |
Kng1 |
kininogen 1 |
|
multiple interactions |
ISO |
11 |
80,109,499 |
80,131,887 |
RGD:6480464 |
CTD |
| G |
Kng1 |
kininogen 1 |
|
affects abundance |
ISO |
11 |
80,109,499 |
80,131,887 |
RGD:6480464 |
CTD |
| G |
Kng1 |
kininogen 1 |
|
increases transport |
ISO |
11 |
80,109,499 |
80,131,887 |
RGD:6480464 |
CTD |
| G |
Kng1 |
kininogen 1 |
|
increases abundance |
ISO |
11 |
80,109,499 |
80,131,887 |
RGD:6480464 |
CTD |
| G |
Kng1 |
kininogen 1 |
|
multiple interactions |
EXP |
11 |
80,109,499 |
80,131,887 |
RGD:6480464 |
CTD |
| G |
Kng1 |
kininogen 1 |
|
increases abundance |
ISO |
11 |
80,109,499 |
80,131,887 |
RGD:6480464 |
CTD |
| G |
Kng1 |
kininogen 1 |
|
multiple interactions |
ISO |
11 |
80,109,499 |
80,131,887 |
RGD:6480464 |
CTD |
| G |
Krt1 |
keratin 1 |
|
multiple interactions |
ISO |
7 |
140,540,960 |
140,546,186 |
RGD:6480464 |
CTD |
| G |
Krt1 |
keratin 1 |
|
increases expression |
ISO |
7 |
140,540,960 |
140,546,186 |
RGD:6480464 |
CTD |
| G |
Krt1 |
keratin 1 |
|
increases expression |
ISO |
7 |
140,540,960 |
140,546,186 |
RGD:6480464 |
CTD |
| G |
Krt1 |
keratin 1 |
|
multiple interactions |
ISO |
7 |
140,540,960 |
140,546,186 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
multiple interactions |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
increases transport |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
multiple interactions |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
affects abundance |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
decreases abundance |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
affects expression |
EXP |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
affects secretion |
EXP |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
multiple interactions |
EXP |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lepr |
leptin receptor |
|
affects expression |
EXP |
5 |
122,320,075 |
122,503,449 |
RGD:6480464 |
CTD |
| G |
Lif |
leukemia inhibitory factor |
|
increases abundance |
EXP |
14 |
84,887,856 |
84,890,630 |
RGD:6480464 |
CTD |
| G |
Lor |
loricrin |
|
increases expression |
ISO |
2 |
184,953,538 |
184,955,283 |
RGD:6480464 |
CTD |
| G |
Lor |
loricrin |
|
multiple interactions |
ISO |
2 |
184,953,538 |
184,955,283 |
RGD:6480464 |
CTD |
| G |
Lphn1 |
latrophilin 1 |
|
multiple interactions |
EXP |
19 |
25,891,157 |
25,931,128 |
RGD:6480464 |
CTD |
| G |
Lphn2 |
latrophilin 2 |
|
multiple interactions |
EXP |
2 |
247,060,645 |
247,201,904 |
RGD:6480464 |
CTD |
| G |
Lypla1 |
lysophospholipase I |
|
multiple interactions |
EXP |
5 |
14,882,196 |
14,911,284 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
multiple interactions |
EXP |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
|
affects expression |
EXP |
7 |
10,074,654 |
10,094,003 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
affects expression |
EXP |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk4 |
mitogen-activated protein kinase 4 |
|
affects expression |
EXP |
18 |
70,707,645 |
70,755,517 |
RGD:6480464 |
CTD |
| G |
Marco |
macrophage receptor with collagenous structure |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mcoln1 |
mucolipin 1 |
|
multiple interactions |
ISO |
12 |
2,640,030 |
2,653,923 |
RGD:6480464 |
CTD |
| G |
Mcu |
mitochondrial calcium uniporter |
|
affects localization |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mgp |
matrix Gla protein |
|
multiple interactions |
ISO |
4 |
173,910,595 |
173,913,917 |
RGD:6480464 |
CTD |
| G |
Mgp |
matrix Gla protein |
|
affects binding |
ISO |
4 |
173,910,595 |
173,913,917 |
RGD:6480464 |
CTD |
| G |
Mgp |
matrix Gla protein |
|
affects expression |
EXP |
4 |
173,910,595 |
173,913,917 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
affects expression |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
multiple interactions |
EXP |
5 |
165,531,402 |
165,640,899 |
RGD:6480464 |
CTD |
| G |
Myl3 |
myosin, light chain 3, alkali; ventricular, skeletal, slow |
|
affects expression |
EXP |
8 |
115,140,705 |
115,146,827 |
RGD:6480464 |
CTD |
| G |
Myl9 |
myosin, light chain 9, regulatory |
|
multiple interactions |
EXP |
3 |
147,190,252 |
147,193,865 |
RGD:6480464 |
CTD |
| G |
Myl9 |
myosin, light chain 9, regulatory |
|
decreases phosphorylation |
EXP |
3 |
147,190,252 |
147,193,865 |
RGD:6480464 |
CTD |
| G |
Myl9 |
myosin, light chain 9, regulatory |
|
affects phosphorylation |
EXP |
3 |
147,190,252 |
147,193,865 |
RGD:6480464 |
CTD |
| G |
Myl9 |
myosin, light chain 9, regulatory |
|
multiple interactions |
EXP |
3 |
147,190,252 |
147,193,865 |
RGD:6480464 |
CTD |
| G |
Mylk |
myosin light chain kinase |
|
increases activity |
ISO |
11 |
67,602,540 |
67,848,794 |
RGD:6480464 |
CTD |
| G |
Mylk |
myosin light chain kinase |
|
multiple interactions |
ISO |
11 |
67,602,540 |
67,848,794 |
RGD:6480464 |
CTD |
| G |
Mylk |
myosin light chain kinase |
|
multiple interactions |
EXP |
11 |
67,602,540 |
67,848,794 |
RGD:6480464 |
CTD |
| G |
Mylk |
myosin light chain kinase |
|
increases activity |
ISO |
11 |
67,602,540 |
67,848,794 |
RGD:6480464 |
CTD |
| G |
Myo1b |
myosin Ib |
|
increases activity |
EXP |
9 |
46,756,678 |
46,917,169 |
RGD:6480464 |
CTD |
| G |
Myo5a |
myosin VA |
|
affects activity |
ISO |
8 |
79,909,224 |
80,027,290 |
RGD:6480464 |
CTD |
| G |
Ndufs1 |
NADH dehydrogenase (ubiquinone) Fe-S protein 1 |
|
multiple interactions |
EXP |
9 |
61,798,141 |
61,831,964 |
RGD:6480464 |
CTD |
| G |
Nedd4 |
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase |
|
affects expression |
EXP |
8 |
77,252,500 |
77,337,402 |
RGD:6480464 |
CTD |
| G |
Nefl |
neurofilament, light polypeptide |
|
multiple interactions |
EXP |
15 |
47,636,303 |
47,640,176 |
RGD:6480464 |
CTD |
| G |
Nefl |
neurofilament, light polypeptide |
|
multiple interactions |
EXP |
15 |
47,636,303 |
47,640,176 |
RGD:6480464 |
CTD |
| G |
Nefm |
neurofilament, medium polypeptide |
|
multiple interactions |
EXP |
15 |
47,698,371 |
47,703,350 |
RGD:6480464 |
CTD |
| G |
Nek9 |
NIMA-related kinase 9 |
|
affects expression |
EXP |
6 |
109,345,437 |
109,389,174 |
RGD:6480464 |
CTD |
| G |
Nf1 |
neurofibromin 1 |
|
decreases transport |
ISO |
10 |
65,574,833 |
65,766,305 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
affects expression |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Ngb |
neuroglobin |
|
affects transport |
ISO |
6 |
111,231,188 |
111,236,255 |
RGD:6480464 |
CTD |
| G |
Noa1 |
nitric oxide associated 1 |
|
multiple interactions |
EXP |
14 |
33,107,963 |
33,123,993 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
multiple interactions |
EXP |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
affects response to substance |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
affects response to substance |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
increases activity |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nppc |
natriuretic peptide C |
|
increases uptake |
EXP |
9 |
85,434,254 |
85,438,454 |
RGD:6480464 |
CTD |
| G |
Nppc |
natriuretic peptide C |
|
multiple interactions |
EXP |
9 |
85,434,254 |
85,438,454 |
RGD:6480464 |
CTD |
| G |
Npr1 |
natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) |
|
affects expression |
EXP |
2 |
182,724,916 |
182,740,242 |
RGD:6480464 |
CTD |
| G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
|
affects expression |
EXP |
5 |
151,524,685 |
151,528,000 |
RGD:6480464 |
CTD |
| G |
Nr1d2 |
nuclear receptor subfamily 1, group D, member 2 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Nrxn1 |
neurexin 1 |
|
multiple interactions |
ISO |
6 |
14,050,929 |
15,354,069 |
RGD:6480464 |
CTD |
| G |
Nucb2 |
nucleobindin 2 |
|
multiple interactions |
EXP |
1 |
174,605,677 |
174,642,111 |
RGD:6480464 |
CTD |
| G |
Ocln |
occludin |
|
multiple interactions |
ISO |
2 |
31,317,090 |
31,367,485 |
RGD:6480464 |
CTD |
| G |
Olr1519 |
olfactory receptor 1519 |
|
multiple interactions |
ISO |
10 |
61,632,798 |
61,633,733 |
RGD:6480464 |
CTD |
| G |
Oprm1 |
opioid receptor, mu 1 |
|
multiple interactions |
ISO |
1 |
37,535,416 |
37,779,392 |
RGD:6480464 |
CTD |
| G |
Oxt |
oxytocin/neurophysin 1 prepropeptide |
|
multiple interactions |
ISO |
3 |
118,194,219 |
118,195,056 |
RGD:6480464 |
CTD |
| G |
Oxt |
oxytocin/neurophysin 1 prepropeptide |
|
multiple interactions |
EXP |
3 |
118,194,219 |
118,195,056 |
RGD:6480464 |
CTD |
| G |
P2rx3 |
purinergic receptor P2X, ligand-gated ion channel, 3 |
|
multiple interactions |
ISO |
3 |
68,228,045 |
68,270,751 |
RGD:6480464 |
CTD |
| G |
P2rx7 |
purinergic receptor P2X, ligand-gated ion channel, 7 |
|
multiple interactions |
ISO |
12 |
35,074,025 |
35,117,152 |
RGD:6480464 |
CTD |
| G |
P2ry1 |
purinergic receptor P2Y, G-protein coupled, 1 |
|
multiple interactions |
ISO |
2 |
150,460,361 |
150,465,855 |
RGD:6480464 |
CTD |
| G |
P2ry1 |
purinergic receptor P2Y, G-protein coupled, 1 |
|
multiple interactions |
ISO |
2 |
150,460,361 |
150,465,855 |
RGD:6480464 |
CTD |
| G |
P2ry1 |
purinergic receptor P2Y, G-protein coupled, 1 |
|
multiple interactions |
EXP |
2 |
150,460,361 |
150,465,855 |
RGD:6480464 |
CTD |
| G |
P2ry2 |
purinergic receptor P2Y, G-protein coupled, 2 |
|
multiple interactions |
ISO |
1 |
158,440,018 |
158,454,213 |
RGD:6480464 |
CTD |
| G |
P2ry2 |
purinergic receptor P2Y, G-protein coupled, 2 |
|
multiple interactions |
EXP |
1 |
158,440,018 |
158,454,213 |
RGD:6480464 |
CTD |
| G |
P2ry2 |
purinergic receptor P2Y, G-protein coupled, 2 |
|
affects response to substance |
ISO |
1 |
158,440,018 |
158,454,213 |
RGD:6480464 |
CTD |
| G |
P2ry4 |
pyrimidinergic receptor P2Y, G-protein coupled, 4 |
|
multiple interactions |
ISO |
X |
88,589,534 |
88,590,947 |
RGD:6480464 |
CTD |
| G |
P4hb |
prolyl 4-hydroxylase, beta polypeptide |
|
multiple interactions |
EXP |
10 |
109,950,221 |
109,961,716 |
RGD:6480464 |
CTD |
| G |
Pafah1b1 |
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 |
|
increases abundance |
ISO |
10 |
61,955,348 |
62,037,871 |
RGD:6480464 |
CTD |
| G |
Pafah1b1 |
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 |
|
multiple interactions |
ISO |
10 |
61,955,348 |
62,037,871 |
RGD:6480464 |
CTD |
| G |
Pafah1b1 |
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 |
|
multiple interactions |
ISO |
10 |
61,955,348 |
62,037,871 |
RGD:6480464 |
CTD |
| G |
Parg |
poly (ADP-ribose) glycohydrolase |
|
multiple interactions |
ISO |
16 |
7,689,492 |
7,798,104 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pask |
PAS domain containing serine/threonine kinase |
|
multiple interactions |
EXP |
9 |
92,582,177 |
92,623,004 |
RGD:6480464 |
CTD |
| G |
Pax6 |
paired box 6 |
|
affects expression |
EXP |
3 |
91,127,605 |
91,149,178 |
RGD:6480464 |
CTD |
| G |
Pax8 |
paired box 8 |
|
affects expression |
EXP |
3 |
2,671,478 |
2,726,801 |
RGD:6480464 |
CTD |
| G |
Pcdh19 |
protocadherin 19 |
|
affects binding |
ISO |
X |
121,108,772 |
121,209,099 |
RGD:6480464 |
CTD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
increases import |
ISO |
7 |
118,244,385 |
118,262,021 |
RGD:6480464 |
CTD |
| G |
Pik3cb |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta |
|
affects transport |
EXP |
8 |
103,886,682 |
103,957,112 |
RGD:6480464 |
CTD |
| G |
Pik3cd |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
|
affects transport |
ISO |
5 |
166,735,274 |
166,761,189 |
RGD:6480464 |
CTD |
| G |
Pip5k1b |
phosphatidylinositol-4-phosphate 5-kinase, type I, beta |
|
affects expression |
EXP |
1 |
227,689,733 |
227,961,671 |
RGD:6480464 |
CTD |
| G |
Pkd1 |
polycystic kidney disease 1 homolog (human) |
|
multiple interactions |
ISO |
10 |
13,801,445 |
13,848,212 |
RGD:6480464 |
CTD |
| G |
Pkd1 |
polycystic kidney disease 1 homolog (human) |
|
multiple interactions |
ISO |
10 |
13,801,445 |
13,848,212 |
RGD:6480464 |
CTD |
| G |
Pkd2 |
polycystic kidney disease 2 (autosomal dominant) |
|
multiple interactions |
ISO |
14 |
6,349,519 |
6,392,988 |
RGD:6480464 |
CTD |
| G |
Pkd2 |
polycystic kidney disease 2 (autosomal dominant) |
|
multiple interactions |
ISO |
14 |
6,349,519 |
6,392,988 |
RGD:6480464 |
CTD |
| G |
Pkd2 |
polycystic kidney disease 2 (autosomal dominant) |
|
multiple interactions |
ISO |
14 |
6,349,519 |
6,392,988 |
RGD:6480464 |
CTD |
| G |
Pkd2 |
polycystic kidney disease 2 (autosomal dominant) |
|
increases transport |
ISO |
14 |
6,349,519 |
6,392,988 |
RGD:6480464 |
CTD |
| G |
Pklr |
pyruvate kinase, liver and RBC |
|
multiple interactions |
EXP |
2 |
181,214,853 |
181,223,505 |
RGD:6480464 |
CTD |
| G |
Pla2g1b |
phospholipase A2, group IB, pancreas |
|
multiple interactions |
ISO |
12 |
42,405,475 |
42,415,189 |
RGD:6480464 |
CTD |
| G |
Pla2g1b |
phospholipase A2, group IB, pancreas |
|
increases abundance |
ISO |
12 |
42,405,475 |
42,415,189 |
RGD:6480464 |
CTD |
| G |
Pla2g2a |
phospholipase A2, group IIA (platelets, synovial fluid) |
|
increases uptake |
EXP |
5 |
157,654,786 |
157,657,360 |
RGD:6480464 |
CTD |
| G |
Pla2g2a |
phospholipase A2, group IIA (platelets, synovial fluid) |
|
multiple interactions |
EXP |
5 |
157,654,786 |
157,657,360 |
RGD:6480464 |
CTD |
| G |
Pla2g6 |
phospholipase A2, group VI (cytosolic, calcium-independent) |
|
multiple interactions |
EXP |
7 |
117,266,784 |
117,307,172 |
RGD:6480464 |
CTD |
| G |
Pla2g6 |
phospholipase A2, group VI (cytosolic, calcium-independent) |
|
increases activity |
EXP |
7 |
117,266,784 |
117,307,172 |
RGD:6480464 |
CTD |
| G |
Pnoc |
prepronociceptin |
|
decreases abundance |
EXP |
15 |
44,822,635 |
44,835,637 |
RGD:6480464 |
CTD |
| G |
Pon1 |
paraoxonase 1 |
|
multiple interactions |
ISO |
4 |
29,936,314 |
29,964,821 |
RGD:6480464 |
CTD |
| G |
Pon2 |
paraoxonase 2 |
|
affects abundance |
ISO |
4 |
30,033,229 |
30,068,643 |
RGD:6480464 |
CTD |
| G |
Pou6f1 |
POU class 6 homeobox 1 |
|
affects expression |
EXP |
7 |
139,325,783 |
139,332,485 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppp1ca |
protein phosphatase 1, catalytic subunit, alpha isozyme |
|
affects expression |
EXP |
1 |
206,774,719 |
206,778,336 |
RGD:6480464 |
CTD |
| G |
Ppp1cb |
protein phosphatase 1, catalytic subunit, beta isozyme |
|
affects expression |
EXP |
6 |
24,067,544 |
24,099,280 |
RGD:6480464 |
CTD |
| G |
Ppp2ca |
protein phosphatase 2, catalytic subunit, alpha isozyme |
|
affects abundance |
ISO |
10 |
37,621,256 |
37,641,008 |
RGD:6480464 |
CTD |
| G |
Ppp2ca |
protein phosphatase 2, catalytic subunit, alpha isozyme |
|
affects transport |
ISO |
10 |
37,621,256 |
37,641,008 |
RGD:6480464 |
CTD |
| G |
Ppp3r1 |
protein phosphatase 3, regulatory subunit B, alpha |
|
multiple interactions |
ISO |
14 |
98,060,302 |
98,099,092 |
RGD:6480464 |
CTD |
| G |
Ppp3r1 |
protein phosphatase 3, regulatory subunit B, alpha |
|
affects response to substance |
ISO |
14 |
98,060,302 |
98,099,092 |
RGD:6480464 |
CTD |
| G |
Prdx6 |
peroxiredoxin 6 |
|
multiple interactions |
EXP |
13 |
76,824,968 |
76,835,517 |
RGD:6480464 |
CTD |
| G |
Prkca |
protein kinase C, alpha |
|
multiple interactions |
EXP |
10 |
97,367,196 |
97,638,910 |
RGD:6480464 |
CTD |
| G |
Prkca |
protein kinase C, alpha |
|
increases response to substance |
EXP |
10 |
97,367,196 |
97,638,910 |
RGD:6480464 |
CTD |
| G |
Prkcb |
protein kinase C, beta |
|
multiple interactions |
ISO |
1 |
181,117,512 |
181,459,856 |
RGD:6480464 |
CTD |
| G |
Prkcd |
protein kinase C, delta |
|
affects expression |
EXP |
16 |
5,954,218 |
5,975,743 |
RGD:6480464 |
CTD |
| G |
Prkce |
protein kinase C, epsilon |
|
multiple interactions |
ISO |
6 |
9,631,234 |
10,097,311 |
RGD:6480464 |
CTD |
| G |
Prkce |
protein kinase C, epsilon |
|
increases phosphorylation |
ISO |
6 |
9,631,234 |
10,097,311 |
RGD:6480464 |
CTD |
| G |
Prkce |
protein kinase C, epsilon |
|
multiple interactions |
ISO |
6 |
9,631,234 |
10,097,311 |
RGD:6480464 |
CTD |
| G |
Prkce |
protein kinase C, epsilon |
|
multiple interactions |
ISO |
6 |
9,631,234 |
10,097,311 |
RGD:6480464 |
CTD |
| G |
Prkce |
protein kinase C, epsilon |
|
affects response to substance |
ISO |
6 |
9,631,234 |
10,097,311 |
RGD:6480464 |
CTD |
| G |
Prkcg |
protein kinase C, gamma |
|
multiple interactions |
ISO |
1 |
64,145,749 |
64,172,712 |
RGD:6480464 |
CTD |
| G |
Prkd1 |
protein kinase D1 |
|
multiple interactions |
ISO |
6 |
70,364,135 |
70,682,006 |
RGD:6480464 |
CTD |
| G |
Prkd1 |
protein kinase D1 |
|
multiple interactions |
EXP |
6 |
70,364,135 |
70,682,006 |
RGD:6480464 |
CTD |
| G |
Prkg1 |
protein kinase, cGMP-dependent, type 1 |
|
increases response to substance |
ISO |
1 |
234,420,597 |
235,765,375 |
RGD:6480464 |
CTD |
| G |
Prlr |
prolactin receptor |
|
affects expression |
EXP |
2 |
59,507,966 |
59,701,221 |
RGD:6480464 |
CTD |
| G |
Prok2 |
prokineticin 2 |
|
increases abundance |
ISO |
4 |
134,561,300 |
134,574,487 |
RGD:6480464 |
CTD |
| G |
Prok2 |
prokineticin 2 |
|
multiple interactions |
ISO |
4 |
134,561,300 |
134,574,487 |
RGD:6480464 |
CTD |
| G |
Prok2 |
prokineticin 2 |
|
increases abundance |
ISO |
4 |
134,561,300 |
134,574,487 |
RGD:6480464 |
CTD |
| G |
Prokr1 |
prokineticin receptor 1 |
|
multiple interactions |
ISO |
4 |
121,750,651 |
121,758,116 |
RGD:6480464 |
CTD |
| G |
Ptafr |
platelet-activating factor receptor |
|
multiple interactions |
EXP |
5 |
152,565,687 |
152,587,342 |
RGD:6480464 |
CTD |
| G |
Ptgdr2 |
prostaglandin D2 receptor 2 |
|
multiple interactions |
ISO |
1 |
213,437,202 |
213,438,498 |
RGD:6480464 |
CTD |
| G |
Ptger1 |
prostaglandin E receptor 1 (subtype EP1) |
|
multiple interactions |
ISO |
19 |
26,160,729 |
26,163,156 |
RGD:6480464 |
CTD |
| G |
Ptger1 |
prostaglandin E receptor 1 (subtype EP1) |
|
increases abundance |
ISO |
19 |
26,160,729 |
26,163,156 |
RGD:6480464 |
CTD |
| G |
Ptger3 |
prostaglandin E receptor 3 (subtype EP3) |
|
multiple interactions |
EXP |
2 |
255,680,691 |
255,759,202 |
RGD:6480464 |
CTD |
| G |
Ptgir |
prostaglandin I2 (prostacyclin) receptor (IP) |
|
multiple interactions |
ISO |
1 |
77,234,538 |
77,236,921 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
affects expression |
EXP |
3 |
15,343,832 |
15,365,412 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Pth |
parathyroid hormone |
|
multiple interactions |
ISO |
1 |
171,240,596 |
171,243,528 |
RGD:6480464 |
CTD |
| G |
Pth |
parathyroid hormone |
|
decreases expression |
ISO |
1 |
171,240,596 |
171,243,528 |
RGD:6480464 |
CTD |
| G |
Pth |
parathyroid hormone |
|
affects metabolic processing |
ISO |
1 |
171,240,596 |
171,243,528 |
RGD:6480464 |
CTD |
| G |
Pth |
parathyroid hormone |
|
decreases abundance |
EXP |
1 |
171,240,596 |
171,243,528 |
RGD:6480464 |
CTD |
| G |
Pth |
parathyroid hormone |
|
increases abundance |
ISO |
1 |
171,240,596 |
171,243,528 |
RGD:6480464 |
CTD |
| G |
Pth |
parathyroid hormone |
|
multiple interactions |
EXP |
1 |
171,240,596 |
171,243,528 |
RGD:6480464 |
CTD |
| G |
Pth1r |
parathyroid hormone 1 receptor |
|
affects expression |
EXP |
8 |
115,099,763 |
115,119,362 |
RGD:6480464 |
CTD |
| G |
Ptk2b |
protein tyrosine kinase 2 beta |
|
multiple interactions |
ISO |
15 |
45,589,222 |
45,717,866 |
RGD:6480464 |
CTD |
| G |
Ptk2b |
protein tyrosine kinase 2 beta |
|
multiple interactions |
EXP |
15 |
45,589,222 |
45,717,866 |
RGD:6480464 |
CTD |
| G |
Ptpn12 |
protein tyrosine phosphatase, non-receptor type 12 |
|
affects expression |
EXP |
4 |
9,517,642 |
9,589,954 |
RGD:6480464 |
CTD |
| G |
Pygl |
phosphorylase, glycogen, liver |
|
multiple interactions |
EXP |
6 |
92,298,339 |
92,341,347 |
RGD:6480464 |
CTD |
| G |
Pygl |
phosphorylase, glycogen, liver |
|
multiple interactions |
EXP |
6 |
92,298,339 |
92,341,347 |
RGD:6480464 |
CTD |
| G |
Rab7a |
RAB7A, member RAS oncogene family |
|
affects expression |
EXP |
4 |
122,202,685 |
122,220,649 |
RGD:6480464 |
CTD |
| G |
Ralgds |
ral guanine nucleotide dissociation stimulator |
|
affects expression |
EXP |
3 |
7,516,054 |
7,537,651 |
RGD:6480464 |
CTD |
| G |
Rap1a |
RAP1A, member of RAS oncogene family |
|
multiple interactions |
ISO |
2 |
200,980,324 |
201,001,561 |
RGD:6480464 |
CTD |
| G |
Rapgef3 |
Rap guanine nucleotide exchange factor (GEF) 3 |
|
multiple interactions |
ISO |
7 |
136,452,945 |
136,474,659 |
RGD:6480464 |
CTD |
| G |
Rbp1 |
retinol binding protein 1, cellular |
|
affects expression |
EXP |
8 |
103,605,870 |
103,627,390 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
decreases secretion |
EXP |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
multiple interactions |
EXP |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Rgs4 |
regulator of G-protein signaling 4 |
|
multiple interactions |
EXP |
13 |
85,533,882 |
85,540,173 |
RGD:6480464 |
CTD |
| G |
Rps3a |
ribosomal protein S3a |
|
affects expression |
EXP |
2 |
178,092,351 |
178,096,720 |
RGD:6480464 |
CTD |
| G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
|
multiple interactions |
EXP |
10 |
76,657,024 |
76,698,088 |
RGD:6480464 |
CTD |
| G |
Rraga |
Ras-related GTP binding A |
|
affects expression |
EXP |
5 |
105,659,659 |
105,661,254 |
RGD:6480464 |
CTD |
| G |
Ryr1 |
ryanodine receptor 1 (skeletal) |
|
multiple interactions |
EXP |
1 |
84,116,098 |
84,254,503 |
RGD:6480464 |
CTD |
| G |
Ryr1 |
ryanodine receptor 1 (skeletal) |
|
multiple interactions |
ISO |
1 |
84,116,098 |
84,254,503 |
RGD:6480464 |
CTD |
| G |
Ryr1 |
ryanodine receptor 1 (skeletal) |
|
multiple interactions |
ISO |
1 |
84,116,098 |
84,254,503 |
RGD:6480464 |
CTD |
| G |
Ryr1 |
ryanodine receptor 1 (skeletal) |
|
multiple interactions |
ISO |
1 |
84,116,098 |
84,254,503 |
RGD:6480464 |
CTD |
| G |
Ryr1 |
ryanodine receptor 1 (skeletal) |
|
increases abundance |
ISO |
1 |
84,116,098 |
84,254,503 |
RGD:6480464 |
CTD |
| G |
Ryr1 |
ryanodine receptor 1 (skeletal) |
|
increases secretion |
ISO |
1 |
84,116,098 |
84,254,503 |
RGD:6480464 |
CTD |
| G |
Ryr1 |
ryanodine receptor 1 (skeletal) |
|
multiple interactions |
ISO |
1 |
84,116,098 |
84,254,503 |
RGD:6480464 |
CTD |
| G |
Ryr2 |
ryanodine receptor 2, cardiac |
|
multiple interactions |
ISO |
17 |
68,959,042 |
69,544,816 |
RGD:6480464 |
CTD |
| G |
Ryr2 |
ryanodine receptor 2, cardiac |
|
multiple interactions |
EXP |
17 |
68,959,042 |
69,544,816 |
RGD:6480464 |
CTD |
| G |
S100a13 |
S100 calcium binding protein A13 |
|
multiple interactions |
ISO |
2 |
182,790,173 |
182,796,668 |
RGD:6480464 |
CTD |
| G |
S100a6 |
S100 calcium binding protein A6 |
|
affects response to substance |
ISO |
2 |
182,895,080 |
182,896,305 |
RGD:6480464 |
CTD |
| G |
S100a8 |
S100 calcium binding protein A8 |
|
multiple interactions |
ISO |
2 |
182,961,994 |
182,962,513 |
RGD:6480464 |
CTD |
| G |
S100a8 |
S100 calcium binding protein A8 |
|
affects binding |
ISO |
2 |
182,961,994 |
182,962,513 |
RGD:6480464 |
CTD |
| G |
S100a9 |
S100 calcium binding protein A9 |
|
affects binding |
ISO |
2 |
182,985,466 |
182,988,147 |
RGD:6480464 |
CTD |
| G |
S100a9 |
S100 calcium binding protein A9 |
|
multiple interactions |
ISO |
2 |
182,985,466 |
182,988,147 |
RGD:6480464 |
CTD |
| G |
S100g |
S100 calcium binding protein G |
|
affects expression |
EXP |
X |
52,446,817 |
52,449,342 |
RGD:6480464 |
CTD |
| G |
Scgb1a1 |
secretoglobin, family 1A, member 1 (uteroglobin) |
|
increases expression |
ISO |
1 |
211,758,103 |
211,761,651 |
RGD:6480464 |
CTD |
| G |
Sct |
secretin |
|
increases abundance |
ISO |
1 |
201,472,250 |
201,472,944 |
RGD:6480464 |
CTD |
| G |
Selt |
selenoprotein T |
|
multiple interactions |
EXP |
2 |
147,913,245 |
147,929,296 |
RGD:6480464 |
CTD |
| G |
Selt |
selenoprotein T |
|
affects abundance |
EXP |
2 |
147,913,245 |
147,929,296 |
RGD:6480464 |
CTD |
| G |
Slc12a5 |
solute carrier family 12 (potassium-chloride transporter), member 5 |
|
multiple interactions |
EXP |
3 |
156,006,017 |
156,037,915 |
RGD:6480464 |
CTD |
| G |
Slc23a2 |
solute carrier family 23 (nucleobase transporters), member 2 |
|
decreases expression |
ISO |
3 |
119,796,376 |
119,886,011 |
RGD:6480464 |
CTD |
| G |
Slc23a2 |
solute carrier family 23 (nucleobase transporters), member 2 |
|
increases expression |
ISO |
3 |
119,796,376 |
119,886,011 |
RGD:6480464 |
CTD |
| G |
Slc23a2 |
solute carrier family 23 (nucleobase transporters), member 2 |
|
multiple interactions |
ISO |
3 |
119,796,376 |
119,886,011 |
RGD:6480464 |
CTD |
| G |
Slc24a2 |
solute carrier family 24 (sodium/potassium/calcium exchanger), member 2 |
|
increases uptake |
EXP |
5 |
106,295,254 |
106,537,714 |
RGD:6480464 |
CTD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
multiple interactions |
EXP |
2 |
116,036,501 |
116,065,834 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
multiple interactions |
EXP |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc5a1 |
solute carrier family 5 (sodium/glucose cotransporter), member 1 |
|
multiple interactions |
EXP |
14 |
83,311,232 |
83,370,657 |
RGD:6480464 |
CTD |
| G |
Slc8a1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
|
multiple interactions |
EXP |
6 |
4,421,046 |
4,691,716 |
RGD:6480464 |
CTD |
| G |
Slc8a1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
|
increases transport |
EXP |
6 |
4,421,046 |
4,691,716 |
RGD:6480464 |
CTD |
| G |
Slc8a1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
|
multiple interactions |
ISO |
6 |
4,421,046 |
4,691,716 |
RGD:6480464 |
CTD |
| G |
Slc8a1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
|
multiple interactions |
ISO |
6 |
4,421,046 |
4,691,716 |
RGD:6480464 |
CTD |
| G |
Slc8a2 |
solute carrier family 8 (sodium/calcium exchanger), member 2 |
|
increases uptake |
EXP |
1 |
76,473,938 |
76,498,624 |
RGD:6480464 |
CTD |
| G |
Slc8a3 |
solute carrier family 8 (sodium/calcium exchanger), member 3 |
|
increases transport |
EXP |
6 |
105,012,888 |
105,159,942 |
RGD:6480464 |
CTD |
| G |
Slc8a3 |
solute carrier family 8 (sodium/calcium exchanger), member 3 |
|
increases uptake |
EXP |
6 |
105,012,888 |
105,159,942 |
RGD:6480464 |
CTD |
| G |
Slc9a1 |
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 |
|
multiple interactions |
EXP |
5 |
151,680,696 |
151,748,460 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
multiple interactions |
EXP |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
increases uptake |
EXP |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sphk1 |
sphingosine kinase 1 |
|
multiple interactions |
ISO |
10 |
106,641,509 |
106,645,579 |
RGD:6480464 |
CTD |
| G |
Sphk1 |
sphingosine kinase 1 |
|
multiple interactions |
ISO |
10 |
106,641,509 |
106,645,579 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Spp2 |
secreted phosphoprotein 2 |
|
affects expression |
EXP |
9 |
87,297,052 |
87,316,546 |
RGD:6480464 |
CTD |
| G |
Sptan1 |
spectrin, alpha, non-erythrocytic 1 |
|
multiple interactions |
EXP |
3 |
8,956,380 |
9,021,831 |
RGD:6480464 |
CTD |
| G |
Sptan1 |
spectrin, alpha, non-erythrocytic 1 |
|
increases cleavage |
EXP |
3 |
8,956,380 |
9,021,831 |
RGD:6480464 |
CTD |
| G |
Sqstm1 |
sequestosome 1 |
|
affects expression |
EXP |
10 |
35,751,300 |
35,762,630 |
RGD:6480464 |
CTD |
| G |
Src |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
affects transport |
ISO |
3 |
148,157,256 |
148,170,524 |
RGD:6480464 |
CTD |
| G |
Src |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
affects response to substance |
ISO |
3 |
148,157,256 |
148,170,524 |
RGD:6480464 |
CTD |
| G |
Src |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
multiple interactions |
ISO |
3 |
148,157,256 |
148,170,524 |
RGD:6480464 |
CTD |
| G |
Stim1 |
stromal interaction molecule 1 |
|
affects abundance |
ISO |
1 |
159,761,567 |
159,925,836 |
RGD:6480464 |
CTD |
| G |
Stmn1 |
stathmin 1 |
|
affects expression |
EXP |
5 |
153,226,420 |
153,232,084 |
RGD:6480464 |
CTD |
| G |
Sugt1 |
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae) |
|
multiple interactions |
ISO |
15 |
60,840,998 |
60,881,860 |
RGD:6480464 |
CTD |
| G |
Syn2 |
synapsin II |
|
multiple interactions |
ISO |
4 |
151,255,241 |
151,413,220 |
RGD:6480464 |
CTD |
| G |
Syn2 |
synapsin II |
|
decreases abundance |
ISO |
4 |
151,255,241 |
151,413,220 |
RGD:6480464 |
CTD |
| G |
Syt1 |
synaptotagmin I |
|
affects binding |
EXP |
7 |
47,243,375 |
47,795,496 |
RGD:6480464 |
CTD |
| G |
Taok1 |
TAO kinase 1 |
|
affects expression |
EXP |
10 |
66,503,966 |
66,584,625 |
RGD:6480464 |
CTD |
| G |
Tbxa2r |
thromboxane A2 receptor |
|
multiple interactions |
ISO |
7 |
9,867,739 |
9,872,536 |
RGD:6480464 |
CTD |
| G |
Tbxa2r |
thromboxane A2 receptor |
|
increases transport |
ISO |
7 |
9,867,739 |
9,872,536 |
RGD:6480464 |
CTD |
| G |
Tgfa |
transforming growth factor alpha |
|
increases abundance |
ISO |
4 |
120,355,649 |
120,437,772 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases abundance |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases uptake |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgm1 |
transglutaminase 1 (K polypeptide epidermal type I, protein-glutamine-gamma-glutamyltransferase) |
|
increases expression |
ISO |
15 |
33,846,367 |
33,859,615 |
RGD:6480464 |
CTD |
| G |
Tgm1 |
transglutaminase 1 (K polypeptide epidermal type I, protein-glutamine-gamma-glutamyltransferase) |
|
multiple interactions |
ISO |
15 |
33,846,367 |
33,859,615 |
RGD:6480464 |
CTD |
| G |
Timm17a |
translocase of inner mitochondrial membrane 17 homolog A (yeast) |
|
affects expression |
EXP |
13 |
48,297,516 |
48,309,303 |
RGD:6480464 |
CTD |
| G |
Tjp1 |
tight junction protein 1 |
|
multiple interactions |
ISO |
1 |
119,684,774 |
119,750,532 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases import |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b |
|
multiple interactions |
ISO |
7 |
90,606,424 |
90,634,431 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
multiple interactions |
ISO |
15 |
59,397,837 |
59,428,014 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
increases abundance |
ISO |
15 |
59,397,837 |
59,428,014 |
RGD:6480464 |
CTD |
| G |
Tnnc1 |
troponin C type 1 (slow) |
|
affects binding |
ISO |
16 |
6,639,357 |
6,642,331 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
decreases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
affects localization |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp73 |
tumor protein p73 |
|
multiple interactions |
ISO |
5 |
170,848,979 |
171,078,739 |
RGD:6480464 |
CTD |
| G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
|
multiple interactions |
ISO |
5 |
3,531,163 |
3,584,401 |
RGD:6480464 |
CTD |
| G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
|
multiple interactions |
EXP |
5 |
3,531,163 |
3,584,401 |
RGD:6480464 |
CTD |
| G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
|
multiple interactions |
ISO |
5 |
3,531,163 |
3,584,401 |
RGD:6480464 |
CTD |
| G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
|
affects activity |
ISO |
5 |
3,531,163 |
3,584,401 |
RGD:6480464 |
CTD |
| G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
|
multiple interactions |
EXP |
5 |
3,531,163 |
3,584,401 |
RGD:6480464 |
CTD |
| G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
|
multiple interactions |
EXP |
5 |
3,531,163 |
3,584,401 |
RGD:6480464 |
CTD |
| G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
|
multiple interactions |
EXP |
5 |
3,531,163 |
3,584,401 |
RGD:6480464 |
CTD |
| G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
|
multiple interactions |
ISO |
5 |
3,531,163 |
3,584,401 |
RGD:6480464 |
CTD |
| G |
Trpc1 |
transient receptor potential cation channel, subfamily C, member 1 |
|
multiple interactions |
ISO |
8 |
100,770,833 |
100,821,420 |
RGD:6480464 |
CTD |
| G |
Trpc1 |
transient receptor potential cation channel, subfamily C, member 1 |
|
increases transport |
ISO |
8 |
100,770,833 |
100,821,420 |
RGD:6480464 |
CTD |
| G |
Trpc1 |
transient receptor potential cation channel, subfamily C, member 1 |
|
increases uptake |
ISO |
8 |
100,770,833 |
100,821,420 |
RGD:6480464 |
CTD |
| G |
Trpc1 |
transient receptor potential cation channel, subfamily C, member 1 |
|
increases transport |
EXP |
8 |
100,770,833 |
100,821,420 |
RGD:6480464 |
CTD |
| G |
Trpc1 |
transient receptor potential cation channel, subfamily C, member 1 |
|
increases uptake |
EXP |
8 |
100,770,833 |
100,821,420 |
RGD:6480464 |
CTD |
| G |
Trpc1 |
transient receptor potential cation channel, subfamily C, member 1 |
|
decreases transport |
ISO |
8 |
100,770,833 |
100,821,420 |
RGD:6480464 |
CTD |
| G |
Trpc3 |
transient receptor potential cation channel, subfamily C, member 3 |
|
increases transport |
ISO |
2 |
123,117,180 |
123,184,016 |
RGD:6480464 |
CTD |
| G |
Trpc3 |
transient receptor potential cation channel, subfamily C, member 3 |
|
multiple interactions |
ISO |
2 |
123,117,180 |
123,184,016 |
RGD:6480464 |
CTD |
| G |
Trpc3 |
transient receptor potential cation channel, subfamily C, member 3 |
|
multiple interactions |
ISO |
2 |
123,117,180 |
123,184,016 |
RGD:6480464 |
CTD |
| G |
Trpc3 |
transient receptor potential cation channel, subfamily C, member 3 |
|
affects transport |
ISO |
2 |
123,117,180 |
123,184,016 |
RGD:6480464 |
CTD |
| G |
Trpc3 |
transient receptor potential cation channel, subfamily C, member 3 |
|
increases transport |
ISO |
2 |
123,117,180 |
123,184,016 |
RGD:6480464 |
CTD |
| G |
Trpc3 |
transient receptor potential cation channel, subfamily C, member 3 |
|
multiple interactions |
EXP |
2 |
123,117,180 |
123,184,016 |
RGD:6480464 |
CTD |
| G |
Trpc3 |
transient receptor potential cation channel, subfamily C, member 3 |
|
affects secretion |
ISO |
2 |
123,117,180 |
123,184,016 |
RGD:6480464 |
CTD |
| G |
Trpc3 |
transient receptor potential cation channel, subfamily C, member 3 |
|
affects transport |
EXP |
2 |
123,117,180 |
123,184,016 |
RGD:6480464 |
CTD |
| G |
Trpc3 |
transient receptor potential cation channel, subfamily C, member 3 |
|
multiple interactions |
EXP |
2 |
123,117,180 |
123,184,016 |
RGD:6480464 |
CTD |
| G |
Trpc3 |
transient receptor potential cation channel, subfamily C, member 3 |
|
increases transport |
EXP |
2 |
123,117,180 |
123,184,016 |
RGD:6480464 |
CTD |
| G |
Trpc4 |
transient receptor potential cation channel, subfamily C, member 4 |
|
multiple interactions |
ISO |
2 |
143,350,286 |
143,485,716 |
RGD:6480464 |
CTD |
| G |
Trpc4 |
transient receptor potential cation channel, subfamily C, member 4 |
|
increases transport |
ISO |
2 |
143,350,286 |
143,485,716 |
RGD:6480464 |
CTD |
| G |
Trpc4 |
transient receptor potential cation channel, subfamily C, member 4 |
|
multiple interactions |
ISO |
2 |
143,350,286 |
143,485,716 |
RGD:6480464 |
CTD |
| G |
Trpc5 |
transient receptor potential cation channel, subfamily C, member 5 |
|
multiple interactions |
ISO |
X |
33,989,907 |
34,126,175 |
RGD:6480464 |
CTD |
| G |
Trpc5 |
transient receptor potential cation channel, subfamily C, member 5 |
|
increases transport |
ISO |
X |
33,989,907 |
34,126,175 |
RGD:6480464 |
CTD |
| G |
Trpc5 |
transient receptor potential cation channel, subfamily C, member 5 |
|
multiple interactions |
ISO |
X |
33,989,907 |
34,126,175 |
RGD:6480464 |
CTD |
| G |
Trpc5 |
transient receptor potential cation channel, subfamily C, member 5 |
|
affects transport |
ISO |
X |
33,989,907 |
34,126,175 |
RGD:6480464 |
CTD |
| G |
Trpc5 |
transient receptor potential cation channel, subfamily C, member 5 |
|
multiple interactions |
ISO |
X |
33,989,907 |
34,126,175 |
RGD:6480464 |
CTD |
| G |
Trpc5 |
transient receptor potential cation channel, subfamily C, member 5 |
|
increases transport |
ISO |
X |
33,989,907 |
34,126,175 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
multiple interactions |
ISO |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
multiple interactions |
ISO |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
increases uptake |
ISO |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
multiple interactions |
EXP |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
increases uptake |
EXP |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
increases transport |
ISO |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
affects transport |
EXP |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
multiple interactions |
EXP |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
increases transport |
EXP |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
affects transport |
ISO |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
affects transport |
ISO |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpm2 |
transient receptor potential cation channel, subfamily M, member 2 |
|
multiple interactions |
EXP |
20 |
11,053,301 |
11,099,740 |
RGD:6480464 |
CTD |
| G |
Trpm2 |
transient receptor potential cation channel, subfamily M, member 2 |
|
increases transport |
EXP |
20 |
11,053,301 |
11,099,740 |
RGD:6480464 |
CTD |
| G |
Trpm2 |
transient receptor potential cation channel, subfamily M, member 2 |
|
increases transport |
ISO |
20 |
11,053,301 |
11,099,740 |
RGD:6480464 |
CTD |
| G |
Trpm2 |
transient receptor potential cation channel, subfamily M, member 2 |
|
multiple interactions |
ISO |
20 |
11,053,301 |
11,099,740 |
RGD:6480464 |
CTD |
| G |
Trpm2 |
transient receptor potential cation channel, subfamily M, member 2 |
|
multiple interactions |
ISO |
20 |
11,053,301 |
11,099,740 |
RGD:6480464 |
CTD |
| G |
Trpm4 |
transient receptor potential cation channel, subfamily M, member 4 |
|
multiple interactions |
EXP |
1 |
95,773,485 |
95,803,542 |
RGD:6480464 |
CTD |
| G |
Trpm4 |
transient receptor potential cation channel, subfamily M, member 4 |
|
increases activity |
ISO |
1 |
95,773,485 |
95,803,542 |
RGD:6480464 |
CTD |
| G |
Trpm6 |
transient receptor potential cation channel, subfamily M, member 6 |
|
multiple interactions |
ISO |
1 |
222,363,324 |
222,502,191 |
RGD:6480464 |
CTD |
| G |
Trpm7 |
transient receptor potential cation channel, subfamily M, member 7 |
|
increases abundance |
ISO |
3 |
114,320,799 |
114,410,498 |
RGD:6480464 |
CTD |
| G |
Trpm7 |
transient receptor potential cation channel, subfamily M, member 7 |
|
multiple interactions |
ISO |
3 |
114,320,799 |
114,410,498 |
RGD:6480464 |
CTD |
| G |
Trpm8 |
transient receptor potential cation channel, subfamily M, member 8 |
|
multiple interactions |
ISO |
9 |
87,193,779 |
87,278,440 |
RGD:6480464 |
CTD |
| G |
Trpm8 |
transient receptor potential cation channel, subfamily M, member 8 |
|
increases transport |
ISO |
9 |
87,193,779 |
87,278,440 |
RGD:6480464 |
CTD |
| G |
Trpm8 |
transient receptor potential cation channel, subfamily M, member 8 |
|
multiple interactions |
ISO |
9 |
87,193,779 |
87,278,440 |
RGD:6480464 |
CTD |
| G |
Trpm8 |
transient receptor potential cation channel, subfamily M, member 8 |
|
multiple interactions |
ISO |
9 |
87,193,779 |
87,278,440 |
RGD:6480464 |
CTD |
| G |
Trpm8 |
transient receptor potential cation channel, subfamily M, member 8 |
|
multiple interactions |
ISO |
9 |
87,193,779 |
87,278,440 |
RGD:6480464 |
CTD |
| G |
Trpm8 |
transient receptor potential cation channel, subfamily M, member 8 |
|
increases transport |
ISO |
9 |
87,193,779 |
87,278,440 |
RGD:6480464 |
CTD |
| G |
Trpm8 |
transient receptor potential cation channel, subfamily M, member 8 |
|
affects transport |
EXP |
9 |
87,193,779 |
87,278,440 |
RGD:6480464 |
CTD |
| G |
Trpm8 |
transient receptor potential cation channel, subfamily M, member 8 |
|
increases transport |
ISO |
9 |
87,193,779 |
87,278,440 |
RGD:6480464 |
CTD |
| G |
Trpm8 |
transient receptor potential cation channel, subfamily M, member 8 |
|
multiple interactions |
ISO |
9 |
87,193,779 |
87,278,440 |
RGD:6480464 |
CTD |
| G |
Trpm8 |
transient receptor potential cation channel, subfamily M, member 8 |
|
multiple interactions |
ISO |
9 |
87,193,779 |
87,278,440 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
EXP |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
EXP |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
affects import |
ISO |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
EXP |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
EXP |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
EXP |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
EXP |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
EXP |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
increases import |
EXP |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv3 |
transient receptor potential cation channel, subfamily V, member 3 |
|
multiple interactions |
EXP |
10 |
60,126,243 |
60,171,718 |
RGD:6480464 |
CTD |
| G |
Trpv3 |
transient receptor potential cation channel, subfamily V, member 3 |
|
multiple interactions |
ISO |
10 |
60,126,243 |
60,171,718 |
RGD:6480464 |
CTD |
| G |
Trpv3 |
transient receptor potential cation channel, subfamily V, member 3 |
|
multiple interactions |
EXP |
10 |
60,126,243 |
60,171,718 |
RGD:6480464 |
CTD |
| G |
Trpv4 |
transient receptor potential cation channel, subfamily V, member 4 |
|
multiple interactions |
ISO |
12 |
43,226,933 |
43,265,889 |
RGD:6480464 |
CTD |
| G |
Trpv4 |
transient receptor potential cation channel, subfamily V, member 4 |
|
multiple interactions |
ISO |
12 |
43,226,933 |
43,265,889 |
RGD:6480464 |
CTD |
| G |
Trpv6 |
transient receptor potential cation channel, subfamily V, member 6 |
|
multiple interactions |
ISO |
4 |
69,331,973 |
69,347,633 |
RGD:6480464 |
CTD |
| G |
Trpv6 |
transient receptor potential cation channel, subfamily V, member 6 |
|
multiple interactions |
ISO |
4 |
69,331,973 |
69,347,633 |
RGD:6480464 |
CTD |
| G |
Trpv6 |
transient receptor potential cation channel, subfamily V, member 6 |
|
increases uptake |
ISO |
4 |
69,331,973 |
69,347,633 |
RGD:6480464 |
CTD |
| G |
Trpv6 |
transient receptor potential cation channel, subfamily V, member 6 |
|
increases transport |
ISO |
4 |
69,331,973 |
69,347,633 |
RGD:6480464 |
CTD |
| G |
Trpv6 |
transient receptor potential cation channel, subfamily V, member 6 |
|
increases expression |
ISO |
4 |
69,331,973 |
69,347,633 |
RGD:6480464 |
CTD |
| G |
Txn2 |
thioredoxin 2 |
|
decreases response to substance |
ISO |
7 |
115,833,695 |
115,847,690 |
RGD:6480464 |
CTD |
| G |
Ubb |
ubiquitin B |
|
affects expression |
EXP |
10 |
139,578,694 |
139,579,068 |
RGD:6480464 |
CTD |
| G |
Ube2d2 |
ubiquitin-conjugating enzyme E2D 2 |
|
affects expression |
EXP |
18 |
28,426,503 |
28,434,785 |
RGD:6480464 |
CTD |
| G |
Ube2g1 |
ubiquitin-conjugating enzyme E2G 1 |
|
affects expression |
EXP |
10 |
59,495,501 |
59,576,926 |
RGD:6480464 |
CTD |
| G |
Ube2g1 |
ubiquitin-conjugating enzyme E2G 1 |
|
multiple interactions |
EXP |
10 |
59,495,501 |
59,576,926 |
RGD:6480464 |
CTD |
| G |
Ube2i |
ubiquitin-conjugating enzyme E2I |
|
affects expression |
EXP |
10 |
14,509,948 |
14,524,551 |
RGD:6480464 |
CTD |
| G |
Ubtf |
upstream binding transcription factor, RNA polymerase I |
|
affects expression |
EXP |
10 |
91,385,368 |
91,398,458 |
RGD:6480464 |
CTD |
| G |
Ucn |
urocortin |
|
multiple interactions |
EXP |
6 |
25,216,788 |
25,217,618 |
RGD:6480464 |
CTD |
| G |
Vdac1 |
voltage-dependent anion channel 1 |
|
multiple interactions |
EXP |
10 |
37,795,721 |
37,823,253 |
RGD:6480464 |
CTD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
affects metabolic processing |
ISO |
7 |
136,567,614 |
136,617,280 |
RGD:6480464 |
CTD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
affects response to substance |
ISO |
7 |
136,567,614 |
136,617,280 |
RGD:6480464 |
CTD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
affects expression |
EXP |
7 |
136,567,614 |
136,617,280 |
RGD:6480464 |
CTD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
affects abundance |
ISO |
7 |
136,567,614 |
136,617,280 |
RGD:6480464 |
CTD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
affects metabolic processing |
ISO |
7 |
136,567,614 |
136,617,280 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
affects expression |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vim |
vimentin |
|
multiple interactions |
EXP |
17 |
87,847,280 |
87,855,763 |
RGD:6480464 |
CTD |
| G |
Vip |
vasoactive intestinal peptide |
|
decreases abundance |
EXP |
1 |
36,361,513 |
36,369,594 |
RGD:6480464 |
CTD |
| G |
Ywhaz |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide |
|
affects expression |
EXP |
7 |
72,283,825 |
72,306,126 |
RGD:6480464 |
CTD |
calcium dihydroxide
|
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
increases expression |
ISO |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
increases expression |
ISO |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
calcium(0)
|
| G |
Adm |
adrenomedullin |
|
decreases expression |
ISO |
1 |
168,380,255 |
168,382,426 |
RGD:6480464 |
CTD |
| G |
Adra1a |
adrenoceptor alpha 1A |
|
multiple interactions |
ISO |
15 |
46,173,429 |
46,263,198 |
RGD:6480464 |
CTD |
| G |
Adra1a |
adrenoceptor alpha 1A |
|
multiple interactions |
ISO |
15 |
46,173,429 |
46,263,198 |
RGD:6480464 |
CTD |
| G |
Adra1b |
adrenoceptor alpha 1B |
|
multiple interactions |
ISO |
10 |
28,889,092 |
28,946,889 |
RGD:6480464 |
CTD |
| G |
Adra1b |
adrenoceptor alpha 1B |
|
multiple interactions |
ISO |
10 |
28,889,092 |
28,946,889 |
RGD:6480464 |
CTD |
| G |
Adra1d |
adrenoceptor alpha 1D |
|
multiple interactions |
ISO |
3 |
119,279,974 |
119,295,985 |
RGD:6480464 |
CTD |
| G |
Alg2 |
ALG2, alpha-1,3/1,6-mannosyltransferase |
|
affects binding |
ISO |
5 |
64,092,017 |
64,096,576 |
RGD:6480464 |
CTD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
multiple interactions |
ISO |
4 |
152,610,283 |
152,657,891 |
RGD:6480464 |
CTD |
| G |
Alpp |
alkaline phosphatase, placental |
|
affects binding |
ISO |
9 |
85,885,336 |
85,888,082 |
RGD:6480464 |
CTD |
| G |
Anxa5 |
annexin A5 |
|
multiple interactions |
ISO |
2 |
122,949,210 |
122,979,757 |
RGD:6480464 |
CTD |
| G |
Apoe |
apolipoprotein E |
|
affects abundance |
ISO |
1 |
79,003,634 |
79,006,387 |
RGD:6480464 |
CTD |
| G |
Apoe |
apolipoprotein E |
|
affects expression |
EXP |
1 |
79,003,634 |
79,006,387 |
RGD:6480464 |
CTD |
| G |
Apom |
apolipoprotein M |
|
affects expression |
EXP |
20 |
3,754,604 |
3,757,204 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
multiple interactions |
ISO |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
affects abundance |
ISO |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
increases uptake |
EXP |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
Arrb2 |
arrestin, beta 2 |
|
multiple interactions |
EXP |
10 |
57,244,071 |
57,284,166 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
multiple interactions |
EXP |
3 |
118,205,007 |
118,206,985 |
RGD:6480464 |
CTD |
| G |
Best1 |
bestrophin 1 |
|
increases activity |
ISO |
1 |
212,432,811 |
212,449,374 |
RGD:6480464 |
CTD |
| G |
Best1 |
bestrophin 1 |
|
multiple interactions |
ISO |
1 |
212,432,811 |
212,449,374 |
RGD:6480464 |
CTD |
| G |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
|
multiple interactions |
ISO |
4 |
154,895,691 |
155,517,389 |
RGD:6480464 |
CTD |
| G |
Cacna1d |
calcium channel, voltage-dependent, L type, alpha 1D subunit |
|
multiple interactions |
EXP |
16 |
5,383,259 |
5,703,361 |
RGD:6480464 |
CTD |
| G |
Cacna1e |
calcium channel, voltage-dependent, R type, alpha 1E subunit |
|
multiple interactions |
EXP |
13 |
69,367,254 |
69,683,943 |
RGD:6480464 |
CTD |
| G |
Cacna1g |
calcium channel, voltage-dependent, T type, alpha 1G subunit |
|
increases transport |
EXP |
10 |
83,043,636 |
83,112,886 |
RGD:6480464 |
CTD |
| G |
Cacna1g |
calcium channel, voltage-dependent, T type, alpha 1G subunit |
|
increases transport |
ISO |
10 |
83,043,636 |
83,112,886 |
RGD:6480464 |
CTD |
| G |
Cacna1g |
calcium channel, voltage-dependent, T type, alpha 1G subunit |
|
multiple interactions |
ISO |
10 |
83,043,636 |
83,112,886 |
RGD:6480464 |
CTD |
| G |
Cacna1g |
calcium channel, voltage-dependent, T type, alpha 1G subunit |
|
multiple interactions |
EXP |
10 |
83,043,636 |
83,112,886 |
RGD:6480464 |
CTD |
| G |
Cacna1g |
calcium channel, voltage-dependent, T type, alpha 1G subunit |
|
increases transport |
EXP |
10 |
83,043,636 |
83,112,886 |
RGD:6480464 |
CTD |
| G |
Cacna1h |
calcium channel, voltage-dependent, T type, alpha 1H subunit |
|
increases transport |
ISO |
10 |
14,621,372 |
14,679,051 |
RGD:6480464 |
CTD |
| G |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
|
multiple interactions |
ISO |
4 |
15,139,881 |
15,566,740 |
RGD:6480464 |
CTD |
| G |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
|
multiple interactions |
ISO |
4 |
15,139,881 |
15,566,740 |
RGD:6480464 |
CTD |
| G |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
|
increases transport |
EXP |
4 |
15,139,881 |
15,566,740 |
RGD:6480464 |
CTD |
| G |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
|
multiple interactions |
EXP |
4 |
15,139,881 |
15,566,740 |
RGD:6480464 |
CTD |
| G |
Cacna2d2 |
calcium channel, voltage-dependent, alpha 2/delta subunit 2 |
|
affects transport |
ISO |
8 |
112,643,409 |
112,775,460 |
RGD:6480464 |
CTD |
| G |
Cacna2d4 |
calcium channel, voltage-dependent, alpha 2/delta subunit 4 |
|
multiple interactions |
ISO |
4 |
155,546,301 |
155,658,429 |
RGD:6480464 |
CTD |
| G |
Cacnb3 |
calcium channel, voltage-dependent, beta 3 subunit |
|
multiple interactions |
ISO |
7 |
137,384,752 |
137,394,283 |
RGD:6480464 |
CTD |
| G |
Cacnb3 |
calcium channel, voltage-dependent, beta 3 subunit |
|
multiple interactions |
EXP |
7 |
137,384,752 |
137,394,283 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
increases expression |
ISO |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Casr |
calcium-sensing receptor |
|
multiple interactions |
ISO |
11 |
66,084,169 |
66,153,292 |
RGD:6480464 |
CTD |
| G |
Casr |
calcium-sensing receptor |
|
increases activity |
ISO |
11 |
66,084,169 |
66,153,292 |
RGD:6480464 |
CTD |
| G |
Casr |
calcium-sensing receptor |
|
multiple interactions |
ISO |
11 |
66,084,169 |
66,153,292 |
RGD:6480464 |
CTD |
| G |
Casr |
calcium-sensing receptor |
|
increases uptake |
ISO |
11 |
66,084,169 |
66,153,292 |
RGD:6480464 |
CTD |
| G |
Cdc42bpb |
CDC42 binding protein kinase beta (DMPK-like) |
|
affects expression |
EXP |
6 |
136,053,885 |
136,136,234 |
RGD:6480464 |
CTD |
| G |
Cdk5r1 |
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
|
increases cleavage |
ISO |
10 |
68,715,844 |
68,717,045 |
RGD:6480464 |
CTD |
| G |
Cdk5r1 |
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
|
multiple interactions |
ISO |
10 |
68,715,844 |
68,717,045 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
affects expression |
EXP |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Cerk |
ceramide kinase |
|
multiple interactions |
ISO |
7 |
124,139,137 |
124,182,070 |
RGD:6480464 |
CTD |
| G |
Cfb |
complement factor B |
|
multiple interactions |
ISO |
20 |
4,072,124 |
4,077,802 |
RGD:6480464 |
CTD |
| G |
Cfd |
complement factor D (adipsin) |
|
multiple interactions |
ISO |
7 |
11,325,538 |
11,327,261 |
RGD:6480464 |
CTD |
| G |
Cfl1 |
cofilin 1, non-muscle |
|
multiple interactions |
ISO |
1 |
208,133,876 |
208,137,408 |
RGD:6480464 |
CTD |
| G |
Chrm1 |
cholinergic receptor, muscarinic 1 |
|
multiple interactions |
ISO |
1 |
211,351,738 |
211,353,120 |
RGD:6480464 |
CTD |
| G |
Chrm1 |
cholinergic receptor, muscarinic 1 |
|
multiple interactions |
ISO |
1 |
211,351,738 |
211,353,120 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
multiple interactions |
EXP |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
multiple interactions |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
multiple interactions |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
|
affects expression |
EXP |
3 |
161,542,131 |
161,553,801 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
multiple interactions |
ISO |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
affects transport |
ISO |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
multiple interactions |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
F2rl1 |
coagulation factor II (thrombin) receptor-like 1 |
|
multiple interactions |
ISO |
2 |
25,886,177 |
25,899,128 |
RGD:6480464 |
CTD |
| G |
F8 |
coagulation factor VIII, procoagulant component |
|
multiple interactions |
ISO |
18 |
121,134 |
162,008 |
RGD:6480464 |
CTD |
| G |
Fgf1 |
fibroblast growth factor 1 (acidic) |
|
increases expression |
EXP |
18 |
31,785,480 |
31,806,452 |
RGD:6480464 |
CTD |
| G |
Fgf23 |
fibroblast growth factor 23 |
|
affects expression |
ISO |
4 |
163,468,604 |
163,476,325 |
RGD:6480464 |
CTD |
| G |
Fgf23 |
fibroblast growth factor 23 |
|
affects expression |
ISO |
4 |
163,468,604 |
163,476,325 |
RGD:6480464 |
CTD |
| G |
Fgf9 |
fibroblast growth factor 9 |
|
affects expression |
EXP |
15 |
37,115,068 |
37,155,652 |
RGD:6480464 |
CTD |
| G |
Fis1 |
fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae) |
|
affects expression |
EXP |
12 |
20,806,840 |
20,821,766 |
RGD:6480464 |
CTD |
| G |
Gcg |
glucagon |
|
multiple interactions |
EXP |
3 |
44,433,180 |
44,438,004 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
multiple interactions |
EXP |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Grm1 |
glutamate receptor, metabotropic 1 |
|
multiple interactions |
EXP |
1 |
5,318,617 |
5,744,593 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
increases import |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
increases import |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
increases import |
ISO |
1 |
202,906,624 |
202,915,231 |
RGD:6480464 |
CTD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
multiple interactions |
ISO |
1 |
202,906,624 |
202,915,231 |
RGD:6480464 |
CTD |
| G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
decreases degradation |
EXP |
9 |
72,003,637 |
72,016,263 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Ilf3 |
interleukin enhancer binding factor 3 |
|
multiple interactions |
ISO |
8 |
20,481,746 |
20,508,850 |
RGD:6480464 |
CTD |
| G |
Jak2 |
Janus kinase 2 |
|
multiple interactions |
ISO |
1 |
232,915,995 |
232,974,763 |
RGD:6480464 |
CTD |
| G |
Kdr |
kinase insert domain receptor |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Kiss1 |
KiSS-1 metastasis-suppressor |
|
multiple interactions |
ISO |
13 |
46,244,786 |
46,247,288 |
RGD:6480464 |
CTD |
| G |
Kiss1r |
KISS1 receptor |
|
multiple interactions |
ISO |
7 |
11,297,840 |
11,301,187 |
RGD:6480464 |
CTD |
| G |
Kng1 |
kininogen 1 |
|
multiple interactions |
EXP |
11 |
80,109,499 |
80,131,887 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
multiple interactions |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
increases transport |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lphn1 |
latrophilin 1 |
|
multiple interactions |
EXP |
19 |
25,891,157 |
25,931,128 |
RGD:6480464 |
CTD |
| G |
Lphn2 |
latrophilin 2 |
|
multiple interactions |
EXP |
2 |
247,060,645 |
247,201,904 |
RGD:6480464 |
CTD |
| G |
Mylk |
myosin light chain kinase |
|
increases activity |
ISO |
11 |
67,602,540 |
67,848,794 |
RGD:6480464 |
CTD |
| G |
Mylk |
myosin light chain kinase |
|
increases activity |
ISO |
11 |
67,602,540 |
67,848,794 |
RGD:6480464 |
CTD |
| G |
Mylk |
myosin light chain kinase |
|
multiple interactions |
ISO |
11 |
67,602,540 |
67,848,794 |
RGD:6480464 |
CTD |
| G |
Mylk |
myosin light chain kinase |
|
multiple interactions |
EXP |
11 |
67,602,540 |
67,848,794 |
RGD:6480464 |
CTD |
| G |
Ndufs1 |
NADH dehydrogenase (ubiquinone) Fe-S protein 1 |
|
multiple interactions |
EXP |
9 |
61,798,141 |
61,831,964 |
RGD:6480464 |
CTD |
| G |
Nedd4 |
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase |
|
affects expression |
EXP |
8 |
77,252,500 |
77,337,402 |
RGD:6480464 |
CTD |
| G |
Nefl |
neurofilament, light polypeptide |
|
multiple interactions |
EXP |
15 |
47,636,303 |
47,640,176 |
RGD:6480464 |
CTD |
| G |
Nefm |
neurofilament, medium polypeptide |
|
multiple interactions |
EXP |
15 |
47,698,371 |
47,703,350 |
RGD:6480464 |
CTD |
| G |
Nek9 |
NIMA-related kinase 9 |
|
affects expression |
EXP |
6 |
109,345,437 |
109,389,174 |
RGD:6480464 |
CTD |
| G |
Nrxn1 |
neurexin 1 |
|
multiple interactions |
ISO |
6 |
14,050,929 |
15,354,069 |
RGD:6480464 |
CTD |
| G |
Pafah1b1 |
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 |
|
increases abundance |
ISO |
10 |
61,955,348 |
62,037,871 |
RGD:6480464 |
CTD |
| G |
Pafah1b1 |
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 |
|
multiple interactions |
ISO |
10 |
61,955,348 |
62,037,871 |
RGD:6480464 |
CTD |
| G |
Pkd2 |
polycystic kidney disease 2 (autosomal dominant) |
|
increases transport |
ISO |
14 |
6,349,519 |
6,392,988 |
RGD:6480464 |
CTD |
| G |
Pkd2 |
polycystic kidney disease 2 (autosomal dominant) |
|
multiple interactions |
ISO |
14 |
6,349,519 |
6,392,988 |
RGD:6480464 |
CTD |
| G |
Pkd2 |
polycystic kidney disease 2 (autosomal dominant) |
|
multiple interactions |
ISO |
14 |
6,349,519 |
6,392,988 |
RGD:6480464 |
CTD |
| G |
Pla2g6 |
phospholipase A2, group VI (cytosolic, calcium-independent) |
|
multiple interactions |
EXP |
7 |
117,266,784 |
117,307,172 |
RGD:6480464 |
CTD |
| G |
Ppp3r1 |
protein phosphatase 3, regulatory subunit B, alpha |
|
multiple interactions |
ISO |
14 |
98,060,302 |
98,099,092 |
RGD:6480464 |
CTD |
| G |
Ppp3r1 |
protein phosphatase 3, regulatory subunit B, alpha |
|
affects response to substance |
ISO |
14 |
98,060,302 |
98,099,092 |
RGD:6480464 |
CTD |
| G |
Prkca |
protein kinase C, alpha |
|
multiple interactions |
EXP |
10 |
97,367,196 |
97,638,910 |
RGD:6480464 |
CTD |
| G |
Prkca |
protein kinase C, alpha |
|
increases response to substance |
EXP |
10 |
97,367,196 |
97,638,910 |
RGD:6480464 |
CTD |
| G |
Prkcb |
protein kinase C, beta |
|
multiple interactions |
ISO |
1 |
181,117,512 |
181,459,856 |
RGD:6480464 |
CTD |
| G |
Prkcd |
protein kinase C, delta |
|
affects expression |
EXP |
16 |
5,954,218 |
5,975,743 |
RGD:6480464 |
CTD |
| G |
Prkce |
protein kinase C, epsilon |
|
multiple interactions |
ISO |
6 |
9,631,234 |
10,097,311 |
RGD:6480464 |
CTD |
| G |
Prkce |
protein kinase C, epsilon |
|
increases phosphorylation |
ISO |
6 |
9,631,234 |
10,097,311 |
RGD:6480464 |
CTD |
| G |
Prkce |
protein kinase C, epsilon |
|
multiple interactions |
ISO |
6 |
9,631,234 |
10,097,311 |
RGD:6480464 |
CTD |
| G |
Prkd1 |
protein kinase D1 |
|
multiple interactions |
ISO |
6 |
70,364,135 |
70,682,006 |
RGD:6480464 |
CTD |
| G |
Prkd1 |
protein kinase D1 |
|
multiple interactions |
EXP |
6 |
70,364,135 |
70,682,006 |
RGD:6480464 |
CTD |
| G |
Prkg1 |
protein kinase, cGMP-dependent, type 1 |
|
increases response to substance |
ISO |
1 |
234,420,597 |
235,765,375 |
RGD:6480464 |
CTD |
| G |
Ryr1 |
ryanodine receptor 1 (skeletal) |
|
multiple interactions |
ISO |
1 |
84,116,098 |
84,254,503 |
RGD:6480464 |
CTD |
| G |
Ryr1 |
ryanodine receptor 1 (skeletal) |
|
multiple interactions |
ISO |
1 |
84,116,098 |
84,254,503 |
RGD:6480464 |
CTD |
| G |
Ryr1 |
ryanodine receptor 1 (skeletal) |
|
multiple interactions |
EXP |
1 |
84,116,098 |
84,254,503 |
RGD:6480464 |
CTD |
| G |
Ryr2 |
ryanodine receptor 2, cardiac |
|
multiple interactions |
ISO |
17 |
68,959,042 |
69,544,816 |
RGD:6480464 |
CTD |
| G |
Ryr2 |
ryanodine receptor 2, cardiac |
|
multiple interactions |
EXP |
17 |
68,959,042 |
69,544,816 |
RGD:6480464 |
CTD |
| G |
Slc12a5 |
solute carrier family 12 (potassium-chloride transporter), member 5 |
|
multiple interactions |
EXP |
3 |
156,006,017 |
156,037,915 |
RGD:6480464 |
CTD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
multiple interactions |
EXP |
2 |
116,036,501 |
116,065,834 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
multiple interactions |
EXP |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc5a1 |
solute carrier family 5 (sodium/glucose cotransporter), member 1 |
|
multiple interactions |
EXP |
14 |
83,311,232 |
83,370,657 |
RGD:6480464 |
CTD |
| G |
Slc8a3 |
solute carrier family 8 (sodium/calcium exchanger), member 3 |
|
increases transport |
EXP |
6 |
105,012,888 |
105,159,942 |
RGD:6480464 |
CTD |
| G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
|
multiple interactions |
ISO |
5 |
3,531,163 |
3,584,401 |
RGD:6480464 |
CTD |
| G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
|
multiple interactions |
EXP |
5 |
3,531,163 |
3,584,401 |
RGD:6480464 |
CTD |
| G |
Trpc1 |
transient receptor potential cation channel, subfamily C, member 1 |
|
multiple interactions |
ISO |
8 |
100,770,833 |
100,821,420 |
RGD:6480464 |
CTD |
| G |
Trpc1 |
transient receptor potential cation channel, subfamily C, member 1 |
|
increases transport |
ISO |
8 |
100,770,833 |
100,821,420 |
RGD:6480464 |
CTD |
| G |
Trpc3 |
transient receptor potential cation channel, subfamily C, member 3 |
|
increases transport |
ISO |
2 |
123,117,180 |
123,184,016 |
RGD:6480464 |
CTD |
| G |
Trpc4 |
transient receptor potential cation channel, subfamily C, member 4 |
|
multiple interactions |
ISO |
2 |
143,350,286 |
143,485,716 |
RGD:6480464 |
CTD |
| G |
Trpc4 |
transient receptor potential cation channel, subfamily C, member 4 |
|
increases transport |
ISO |
2 |
143,350,286 |
143,485,716 |
RGD:6480464 |
CTD |
| G |
Trpc5 |
transient receptor potential cation channel, subfamily C, member 5 |
|
multiple interactions |
ISO |
X |
33,989,907 |
34,126,175 |
RGD:6480464 |
CTD |
| G |
Trpc5 |
transient receptor potential cation channel, subfamily C, member 5 |
|
increases transport |
ISO |
X |
33,989,907 |
34,126,175 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
multiple interactions |
ISO |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
multiple interactions |
ISO |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
increases uptake |
ISO |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
multiple interactions |
EXP |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
increases uptake |
EXP |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
affects transport |
ISO |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
increases transport |
ISO |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
affects transport |
EXP |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
multiple interactions |
EXP |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
increases transport |
EXP |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpm2 |
transient receptor potential cation channel, subfamily M, member 2 |
|
multiple interactions |
EXP |
20 |
11,053,301 |
11,099,740 |
RGD:6480464 |
CTD |
| G |
Trpm2 |
transient receptor potential cation channel, subfamily M, member 2 |
|
increases transport |
EXP |
20 |
11,053,301 |
11,099,740 |
RGD:6480464 |
CTD |
| G |
Trpm2 |
transient receptor potential cation channel, subfamily M, member 2 |
|
increases transport |
ISO |
20 |
11,053,301 |
11,099,740 |
RGD:6480464 |
CTD |
| G |
Trpm4 |
transient receptor potential cation channel, subfamily M, member 4 |
|
multiple interactions |
EXP |
1 |
95,773,485 |
95,803,542 |
RGD:6480464 |
CTD |
| G |
Trpm4 |
transient receptor potential cation channel, subfamily M, member 4 |
|
increases activity |
ISO |
1 |
95,773,485 |
95,803,542 |
RGD:6480464 |
CTD |
| G |
Trpm6 |
transient receptor potential cation channel, subfamily M, member 6 |
|
multiple interactions |
ISO |
1 |
222,363,324 |
222,502,191 |
RGD:6480464 |
CTD |
| G |
Trpm7 |
transient receptor potential cation channel, subfamily M, member 7 |
|
increases abundance |
ISO |
3 |
114,320,799 |
114,410,498 |
RGD:6480464 |
CTD |
| G |
Trpm7 |
transient receptor potential cation channel, subfamily M, member 7 |
|
multiple interactions |
ISO |
3 |
114,320,799 |
114,410,498 |
RGD:6480464 |
CTD |
| G |
Trpm8 |
transient receptor potential cation channel, subfamily M, member 8 |
|
multiple interactions |
ISO |
9 |
87,193,779 |
87,278,440 |
RGD:6480464 |
CTD |
| G |
Trpm8 |
transient receptor potential cation channel, subfamily M, member 8 |
|
increases transport |
ISO |
9 |
87,193,779 |
87,278,440 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
EXP |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
EXP |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv3 |
transient receptor potential cation channel, subfamily V, member 3 |
|
multiple interactions |
EXP |
10 |
60,126,243 |
60,171,718 |
RGD:6480464 |
CTD |
| G |
Trpv3 |
transient receptor potential cation channel, subfamily V, member 3 |
|
multiple interactions |
ISO |
10 |
60,126,243 |
60,171,718 |
RGD:6480464 |
CTD |
| G |
Trpv3 |
transient receptor potential cation channel, subfamily V, member 3 |
|
multiple interactions |
EXP |
10 |
60,126,243 |
60,171,718 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vim |
vimentin |
|
multiple interactions |
EXP |
17 |
87,847,280 |
87,855,763 |
RGD:6480464 |
CTD |
Term paths to the root
|